Tag: hormoneReceptorNegative

Articles

• Aspirin and breast cancer
• Birth control pill use and breast cancer
• Breast cancer in Asian Americans
• Breast cancer types
• Foods to eat & avoid for triple negative (ER-/PR-/HER2-) breast cancer
• Latinas less likely to develop BC but outcomes are less favorable
• Obesity increases risk of breast cancer and worsens prognosis
• Triple negative (ER-/PR-/HER2-) breast cancer prognosis

News

04/01/17

Saffron carotenoid crocin inhibits breast cancer cell division

03/12/17

Sulforaphane in broccoli heightens taxane effects against TN disease

10/03/16

Anthocyanin found primarily in red & black fruits inhibits TN BC

07/04/16

Radiotherapy after lumpectomy improves survival in older ER- women

05/16/16

Fruit consumption in adolescence linked to lower BC risk

08/01/15

Garlic compound inhibits protein folding in triple negative BC cells

02/07/15

Coffee linked to lower risk of postmenopausal BC, especially ER-/PR-

11/23/14

Black pepper compound inhibits TN cell growth and movement

10/05/14

Walnut compounds impair BC energy supply and induce cell death

03/09/14

Reconstruction using fat stem cells could promote TN metastasis

06/24/13

Social isolation promotes mammary tumors in mouse model of TN BC

03/29/13

Blueberry compound inhibits BC stem cell generation and activities

10/30/12

Prognosis of triple negative BC varies according histological type

10/17/12

Pomegranate juice inhibits metastatic processes in BC cells

10/14/12

Fatty fish compound DHA increases Adriamycin efficacy in TN cells

05/15/12

Blueberries and raspberries both reduce mammary tumor development

04/12/12

Five-year prognosis by breast cancer subtype

02/22/12

Selenium increases effectiveness of Taxol for TN breast cancer

02/20/12

Cruciferous vegetable consumption linked to reduced risk of cancer

12/02/11

Knowing receptor status of metastases improves treatment decisions

11/17/11

Brown seaweed compound fucoidan induces breast cancer cell death

10/22/11

Young breast cancer patients require aggressive treatment

10/20/11

Age and breast cancer subtype influence prognosis after lumpectomy

09/15/11

High lignan intake may improve survival among women with ER- BC

08/01/11

BC subtype influences prognosis after neoadjuvant chemotherapy

06/09/11

Patients with ER-/PR+ breast cancer benefit from endocrine therapy

05/28/11

Triple negative prognosis is influenced by number of positive nodes

03/02/11

Risk of second primary breast cancer highest in ER-/PR- survivors

02/25/11

Not giving birth reduces risk of triple negative breast cancer

01/16/11

Patterns of BC in Black women suggest mammograms should start in 40s

11/30/10

Small triple negative tumors have worse prognosis than small ER+/PR+

10/15/10

Vegetables can reduce risk of ER-/PR- BC in African Americans

09/14/10

Does a family history of BC increase the risk of certain subtypes?

02/22/10

Benign breast disease less likely to progress if having children young

02/05/10

Vitamin D and calcium intakes influence risk of breast cancer

Studies

• Radiotherapy is recommended for hormone receptor-negative older breast cancer patients after breast conserving surgery Cite
  Liu Y, Li J, Li H, Zhang G, Li C, Wei C, et al. Radiotherapy is recommended for hormone receptor-negative older breast cancer patients after breast conserving surgery. Scientific Reports. Springer Science and Business Media LLC; 2024; 14 10.1038/s41598-024-66401-6
• Circulating Estrogen Metabolites and Risk of Breast Cancer among Postmenopausal Women in the Nurses’ Health Study Cite
  Brantley KD, Ziegler RG, Craft NE, Hankinson SE, Eliassen AH. Circulating Estrogen Metabolites and Risk of Breast Cancer among Postmenopausal Women in the Nurses’ Health Study. Cancer Epidemiology, Biomarkers & Prevention. American Association for Cancer Research (AACR); 2024; 10.1158/1055-9965.epi-24-0577
• Pregnancy-Related Factors and Breast Cancer Risk for Women Across a Range of Familial Risk Cite
  McDonald JA, Liao Y, Knight JA, John EM, Kurian AW, Daly M, et al. Pregnancy-Related Factors and Breast Cancer Risk for Women Across a Range of Familial Risk. JAMA Network Open. American Medical Association (AMA); 2024; 7:e2427441 10.1001/jamanetworkopen.2024.27441
• Recreational physical activity and breast cancer risk by menopausal status and tumor hormone receptor status: results from the Nurses’ Health Studies Cite
  Fortner RT, Brantley KD, Tworoger SS, Tamimi RM, Rosner B, Holmes MD, et al. Recreational physical activity and breast cancer risk by menopausal status and tumor hormone receptor status: results from the Nurses’ Health Studies. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2024; 206:77-90 10.1007/s10549-023-07238-x
• Dose/Exposure Relationship of Exercise and Distant Recurrence in Primary Breast Cancer Cite
  Soldato D, Michiels S, Havas J, Di Meglio A, Pagliuca M, Franzoi MA, et al. Dose/Exposure Relationship of Exercise and Distant Recurrence in Primary Breast Cancer. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2024; 10.1200/jco.23.01959
• Association between pre-diagnosis recreational physical activity and risk of breast cancer recurrence: the California Teachers Study Cite
  Lin D, Thompson CL, Demalis A, Derbes R, Al-Shaar L, Spielfogel ES, et al. Association between pre-diagnosis recreational physical activity and risk of breast cancer recurrence: the California Teachers Study. Cancer Causes & Control. Springer Science and Business Media LLC; 2024; 10.1007/s10552-024-01870-8
• Analysis of Breast Cancer Mortality in the US—1975 to 2019 Cite
  Caswell-Jin JL, Sun LP, Munoz D, Lu Y, Li Y, Huang H, et al. Analysis of Breast Cancer Mortality in the US—1975 to 2019. JAMA. American Medical Association (AMA); 2024; 331:233 10.1001/jama.2023.25881
• Estrogen Receptor-negative Ductal Carcinoma In Situ (DCIS) of the Breast – an Institutional Review of Outcomes Cite
  ZABROCKA E, NEWMAN B, LEVEY G, SWEENEY K, OENTORO J, RYU S, et al. Estrogen Receptor-negative Ductal Carcinoma In Situ (DCIS) of the Breast – an Institutional Review of Outcomes. Anticancer Research. Anticancer Research USA Inc.; 2023; 43:4031-4036 10.21873/anticanres.16591
• Risk of estrogen receptor–specific breast cancer by family history of estrogen receptor subtypes and other cancers Cite
  Wang Q, Zhang Y, Zeng E, Grassmann F, He W, Czene K. Risk of estrogen receptor–specific breast cancer by family history of estrogen receptor subtypes and other cancers. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2023; 10.1093/jnci/djad104
• Association of Antibiotic Exposure with Residual Cancer Burden and Pathologic Complete Response in Patients with HER2-negative stage II or III breast cancer Treated with Neoadjuvant Pembrolizumab in the ISPY-2 Trial Cite
  Kulkarni A, Jain A, Jewett P, Desai N, Veer LV', Hirst G, et al. Association of Antibiotic Exposure with Residual Cancer Burden and Pathologic Complete Response in Patients with HER2-negative stage II or III breast cancer Treated with Neoadjuvant Pembrolizumab in the ISPY-2 Trial. Research Square Platform LLC; 2023; 10.21203/rs.3.rs-3179847/v1
• Breast cancer mortality in 500 000 women with early invasive breast cancer in England, 1993-2015: population based observational cohort study Cite
  Taylor C, McGale P, Probert J, Broggio J, Charman J, Darby SC, et al. Breast cancer mortality in 500 000 women with early invasive breast cancer in England, 1993-2015: population based observational cohort study. BMJ. BMJ; 2023;:e074684 10.1136/bmj-2022-074684
• Stressful Life Events, Social Support, and Incident Breast Cancer by Estrogen Receptor Status Cite
  Lawrence WR, McDonald JA, Williams F, Shiels MS, Freedman ND, Lin Z, et al. Stressful Life Events, Social Support, and Incident Breast Cancer by Estrogen Receptor Status. Cancer Prevention Research. American Association for Cancer Research (AACR); 2023;:OF1-OF10 10.1158/1940-6207.capr-22-0472
• Overall survival of patients with metastatic breast cancer in Sweden: a nationwide study Cite
  Valachis A, Carlqvist P, Ma Y, Szilcz M, Freilich J, Vertuani S, et al. Overall survival of patients with metastatic breast cancer in Sweden: a nationwide study. British Journal of Cancer. Springer Science and Business Media LLC; 2022; 10.1038/s41416-022-01845-z
• Impact of Diabetes on Patient Outcomes in Breast Cancer Patients Cite
  Tobe A, Horimoto Y, Kobayashi K, Kamisada N, Hirano M. Impact of Diabetes on Patient Outcomes in Breast Cancer Patients. Breast Care. S. Karger AG; 2022; 10.1159/000524513
• Estrogen receptor negative breast cancer incidence rates are similar in Ghanaian and Non-Hispanic Black women in the USA Cite
  Davis Lynn BC, Figueroa J, Awittor FK, Ohene Oti NO, Edusei L, Titiloye N, et al. Estrogen receptor negative breast cancer incidence rates are similar in Ghanaian and Non-Hispanic Black women in the USA. Cold Spring Harbor Laboratory; 2022; 10.1101/2022.02.21.22271266
• Oral Contraceptive Use in BRCA1 and BRCA2 Mutation Carriers: Absolute Cancer Risks and Benefits. Cite
  Schrijver LH, Mooij TM, Pijpe A, Sonke GS, Mourits MJ, Andrieu N, et al. Oral Contraceptive Use in BRCA1 and BRCA2 Mutation Carriers: Absolute Cancer Risks and Benefits.. Apollo - University of Cambridge Repository; 2022; 10.17863/CAM.80147
• Abstract PO-170: Association between outdoor ambient benzene and invasive breast cancer incidence: The Multiethnic Cohort Study Cite
  Ihenacho U, Wu J, Tseng C, Yang J, Fruin S, Larson T, et al. Abstract PO-170: Association between outdoor ambient benzene and invasive breast cancer incidence: The Multiethnic Cohort Study. Epidemiology, Lifestyle, and Genetics: Neighborhood Factors. American Association for Cancer Research; 2022; 10.1158/1538-7755.disp21-po-170
• The Other Side of the Coin: May Androgens Have a Role in Breast Cancer Risk? Cite
  Chiodo C, Morelli C, Cavaliere F, Sisci D, Lanzino M. The Other Side of the Coin: May Androgens Have a Role in Breast Cancer Risk?. International Journal of Molecular Sciences. MDPI AG; 2021; 23:424 10.3390/ijms23010424
• Residential ultraviolet radiation and breast cancer risk in a large prospective cohort Cite
  Gregoire AM, VoPham T, Laden F, Yarosh R, O'Brien KM, Sandler DP, et al. Residential ultraviolet radiation and breast cancer risk in a large prospective cohort. Environment International. Elsevier BV; 2022; 159:107028 10.1016/j.envint.2021.107028
• Breast Cancer in Chinese Females Aged 25 Years and Younger Cite
  Li L, Lv D, Zhai J, Zhang D, Guan X, Ma F. Breast Cancer in Chinese Females Aged 25 Years and Younger. Journal of Oncology. Hindawi Limited; 2021; 2021:1-9 10.1155/2021/4891936
• The effects of vitamin D (Vit D) replacement on pathological complete response (PCR) in breast cancer (BC) patients receiving neoadjuvant systemic chemotherapy (NAC). Cite
  Ozmen V, Ordu C, Ilgun AS, Unal C, Soybir G, Erdogan Z, et al. The effects of vitamin D (Vit D) replacement on pathological complete response (PCR) in breast cancer (BC) patients receiving neoadjuvant systemic chemotherapy (NAC).. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2021; 39:e12604-e12604 10.1200/jco.2021.39.15_suppl.e12604
• Facile preparation of Au nanoparticles mediated by Foeniculum Vulgare aqueous extract and investigation of the anti-human breast carcinoma effects Cite
  Chen J, Ding J, Li D, Wang Y, Wu Y, Yang X, et al. Facile preparation of Au nanoparticles mediated by Foeniculum Vulgare aqueous extract and investigation of the anti-human breast carcinoma effects. Arabian Journal of Chemistry. Elsevier BV; 2021;:103479 10.1016/j.arabjc.2021.103479
• Effect of Contralateral Prophylactic Mastectomy on Overall Survival in Patients with Hormone Receptor Negative Breast Cancer Cite
  Su YC, Zheng X. Effect of Contralateral Prophylactic Mastectomy on Overall Survival in Patients with Hormone Receptor Negative Breast Cancer. Research Square Platform LLC; 2021; 10.21203/rs.3.rs-674088/v1
• Mechanistic Targets of Diallyl Trisulfide in Human Breast Cancer Cells Identified by RNA-seq Analysis Cite
  Hahm E, Kim S, Mathan SV, Singh RP, Singh SV. Mechanistic Targets of Diallyl Trisulfide in Human Breast Cancer Cells Identified by RNA-seq Analysis. Journal of Cancer Prevention. Korean Society of Cancer Prevention; 2021; 26:128-136 10.15430/jcp.2021.26.2.128
• Inflammatory cytokines and distant recurrence in HER2-negative early breast cancer in the ECOG-ACRIN 5103 trial. Cite
  Sparano JA, O'Neill AM, Graham N, Northfelt DW, Dang CT, Wolff AC, et al. Inflammatory cytokines and distant recurrence in HER2-negative early breast cancer in the ECOG-ACRIN 5103 trial.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2021; 39:520-520 10.1200/jco.2021.39.15_suppl.520
• Factors associated with late risks of breast cancer-specific mortality in the SEER registry Cite
  Leone JP, Vallejo CT, Hassett MJ, Leone J, Graham N, Tayob N, et al. Factors associated with late risks of breast cancer-specific mortality in the SEER registry. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2021; 10.1007/s10549-021-06233-4
• Urinary phthalate exposures and risk of breast cancer: the Multiethnic Cohort study Cite
  Wu AH, Franke AA, Wilkens LR, Tseng C, Conroy SM, Li Y, et al. Urinary phthalate exposures and risk of breast cancer: the Multiethnic Cohort study. Breast Cancer Research. Springer Science and Business Media LLC; 2021; 23 10.1186/s13058-021-01419-6
• Predictors of Nodal Pathological Complete Response in Asian Women with Stage II–III Node-Positive Breast Cancer Cite
  Montagna G, Tong Y, Ritter M, Levi J, Weber WP, Chen X, et al. Predictors of Nodal Pathological Complete Response in Asian Women with Stage II–III Node-Positive Breast Cancer. Oncology. S. Karger AG; 2021;:1-6 10.1159/000513454
• Sugar-Sweetened Soda Consumption and Total and Breast Cancer Mortality: The Western New York Exposures and Breast Cancer (WEB) Study Cite
  Koyratty N, McCann SE, Millen AE, Nie J, Trevisan M, Freudenheim JL. Sugar-Sweetened Soda Consumption and Total and Breast Cancer Mortality: The Western New York Exposures and Breast Cancer (WEB) Study. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2021;:cebp.1242.2020 10.1158/1055-9965.epi-20-1242
• Twenty-year risks of breast cancer-specific mortality for stage III breast cancer in the surveillance, epidemiology, and end results registry Cite
  Leone JP, Leone BA, Tayob N, Hassett MJ, Leone J, Freedman RA, et al. Twenty-year risks of breast cancer-specific mortality for stage III breast cancer in the surveillance, epidemiology, and end results registry. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2021; 10.1007/s10549-021-06121-x
• Oleuropein is a natural inhibitor of PAI-1-mediated proliferation in human ER-/PR- breast cancer cells Cite
  Tzekaki EE, Geromichalos G, Lavrentiadou SN, Tsantarliotou MP, Pantazaki AA, Papaspyropoulos A. Oleuropein is a natural inhibitor of PAI-1-mediated proliferation in human ER-/PR- breast cancer cells. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2021; 10.1007/s10549-020-06054-x
• Inhibition of breast cancer stem-like cells by a triterpenoid, ursolic acid, via activation of Wnt antagonist, sFRP4 and suppression of miRNA-499a-5p Cite
  Mandal S, Gamit N, Varier L, Dharmarajan A, Warrier S. Inhibition of breast cancer stem-like cells by a triterpenoid, ursolic acid, via activation of Wnt antagonist, sFRP4 and suppression of miRNA-499a-5p. Life Sciences. Elsevier BV; 2020; 265:118854 10.1016/j.lfs.2020.118854
• Long-term consumption of non-fermented and fermented dairy products and risk of breast cancer by estrogen receptor status – Population-based prospective cohort study Cite
  Kaluza J, Komatsu S, Lauriola M, Harris HR, Bergkvist L, Michaëlsson K, et al. Long-term consumption of non-fermented and fermented dairy products and risk of breast cancer by estrogen receptor status – Population-based prospective cohort study. Clinical Nutrition. Elsevier BV; 2020; 10.1016/j.clnu.2020.09.013
• Docosahexaenoic acid (DHA) inhibits pro-angiogenic effects of breast cancer cells via down-regulating cellular and exosomal expression of angiogenic genes and microRNAs Cite
  Aslan C, Maralbashi S, Kahroba H, Asadi M, Soltani-Zangbar MS, Javadian M, et al. Docosahexaenoic acid (DHA) inhibits pro-angiogenic effects of breast cancer cells via down-regulating cellular and exosomal expression of angiogenic genes and microRNAs. Life Sciences. Elsevier BV; 2020; 258:118094 10.1016/j.lfs.2020.118094
• Abstract C026: Energy-related risk factors and breast cancer subtypes in African American women Cite
  Fortune M, Dujon S, Fadden MK, Lipworth L, Sanderson M. Abstract C026: Energy-related risk factors and breast cancer subtypes in African American women. Poster Presentations - Proffered Abstracts. American Association for Cancer Research; 2020; 10.1158/1538-7755.disp19-c026
• Abstract D101: Breast cancer in Black women: Do risk factors differ for those who have a family history of breast cancer? Cite
  Zirpoli GR, Bethea TN, Bernstein L, Troester MA, Ambrosone CB, Palmer JR. Abstract D101: Breast cancer in Black women: Do risk factors differ for those who have a family history of breast cancer?. Poster Presentations - Proffered Abstracts. American Association for Cancer Research; 2020; 10.1158/1538-7755.disp19-d101
• The impact of menstruation persistence or recovery after chemotherapy on survival in young patients with hormone receptor negative breast cancer Cite
  van Barele M, Heemskerk-Gerritsen BA, van Doorn HC, Schmidt MK, Hooning MJ, Jager A. The impact of menstruation persistence or recovery after chemotherapy on survival in young patients with hormone receptor negative breast cancer. The Breast. Elsevier BV; 2020; 52:102-109 10.1016/j.breast.2020.05.004
• Prognostic Impact of Pregnancy in Korean Patients with Breast Cancer Cite
  Choi M, Han J, Yang BR, Jang M, Kim M, Kim T, et al. Prognostic Impact of Pregnancy in Korean Patients with Breast Cancer. The Oncologist. Wiley; 2019; 24 10.1634/theoncologist.2019-0167
• Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohort Cite
  Darlix A, Louvel G, Fraisse J, Jacot W, Brain E, Debled M, et al. Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohort. British Journal of Cancer. Springer Science and Business Media LLC; 2019; 121:991-1000 10.1038/s41416-019-0619-y
• ER-Negative Breast Cancer Is Highly Responsive to Cholesterol Metabolite Signalling Cite
  Hutchinson SA, Lianto P, Roberg-Larsen H, Battaglia S, Hughes TA, Thorne JL. ER-Negative Breast Cancer Is Highly Responsive to Cholesterol Metabolite Signalling. Nutrients. MDPI AG; 2019; 11:2618 10.3390/nu11112618
• Long-term prognostic effect of hormone receptor subtype on breast cancer Cite
  Hwang K, Kim J, Jung J, Kim BH, Park JH, Jeon SY, et al. Long-term prognostic effect of hormone receptor subtype on breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2019; 179:139-151 10.1007/s10549-019-05456-w
• Epigenetic role of thymoquinone: impact on cellular mechanism and cancer therapeutics Cite
  Khan MA, Tania M, Fu J. Epigenetic role of thymoquinone: impact on cellular mechanism and cancer therapeutics. Drug Discovery Today. Elsevier BV; 2019; 24:2315-2322 10.1016/j.drudis.2019.09.007
• Metallic air pollutants and breast cancer heterogeneity Cite
  Kresovich JK, Erdal S, Chen HY, Gann PH, Argos M, Rauscher GH. Metallic air pollutants and breast cancer heterogeneity. Environmental Research. Elsevier BV; 2019; 177:108639 10.1016/j.envres.2019.108639
• Higher ER load is not associated with better outcome in stage 1–3 breast cancer: a descriptive overview of quantitative HR analysis in operable breast cancer Cite
  Noordhoek I, de Groot AF, Cohen D, Liefers GJ, Portielje JEA, Kroep JR. Higher ER load is not associated with better outcome in stage 1–3 breast cancer: a descriptive overview of quantitative HR analysis in operable breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2019; 176:27-36 10.1007/s10549-019-05233-9
• Reproductive history and breast cancer survival: a prospective patient cohort study in Japan Cite
  Minami Y, Nishino Y, Kawai M, Tada H, Kanemura S, Miyashita M, et al. Reproductive history and breast cancer survival: a prospective patient cohort study in Japan. Breast Cancer. Springer Science and Business Media LLC; 2019; 26:687-702 10.1007/s12282-019-00972-5
• Body mass index, mammographic density, and breast cancer risk by estrogen receptor subtype Cite
  Shieh Y, Scott CG, Jensen MR, Norman AD, Bertrand KA, Pankratz VS, et al. Body mass index, mammographic density, and breast cancer risk by estrogen receptor subtype. Breast Cancer Research. Springer Science and Business Media LLC; 2019; 21 10.1186/s13058-019-1129-9
• Chronic long‐term exposure to cadmium air pollution and breast cancer risk in the French E3N cohort Cite
  Amadou A, Praud D, Coudon T, Danjou AM, Faure E, Leffondré K, et al. Chronic long‐term exposure to cadmium air pollution and breast cancer risk in the French E3N cohort. International Journal of Cancer. Wiley; 2019; 146:341-351 10.1002/ijc.32257
• ERβ modulates genistein’s cisplatin-enhancing activities in breast cancer MDA-MB-231 cells via P53-independent pathway Cite
  Liu R, Xu X, Liang C, Chen X, Yu X, Zhong H, et al. ERβ modulates genistein’s cisplatin-enhancing activities in breast cancer MDA-MB-231 cells via P53-independent pathway. Molecular and Cellular Biochemistry. Springer Science and Business Media LLC; 2019; 456:205-216 10.1007/s11010-019-03505-y
• Abstract P2-02-06: Deregulated lipid metabolism fuels the genesis of estrogen receptor negative breast cancer Cite
  Yadav S, Choi M, VanDerway D, Bauer G, Backman V, Khan S, et al. Abstract P2-02-06: Deregulated lipid metabolism fuels the genesis of estrogen receptor negative breast cancer. Poster Session Abstracts. American Association for Cancer Research; 2019; 10.1158/1538-7445.sabcs18-p2-02-06
• Examination of a paradox: recurrent metastatic breast cancer incidence decline without improved distant disease survival: 1990–2011 Cite
  Malmgren J, Hurlbert M, Atwood M, Kaplan HG. Examination of a paradox: recurrent metastatic breast cancer incidence decline without improved distant disease survival: 1990–2011. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2018; 174:505-514 10.1007/s10549-018-05090-y
• Androgen Receptor Expression and Breast Cancer Survival: Results From the Nurses’ Health Studies Cite
  Kensler KH, Poole EM, Heng YJ, Collins LC, Glass B, Beck AH, et al. Androgen Receptor Expression and Breast Cancer Survival: Results From the Nurses’ Health Studies. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2018; 111:700-708 10.1093/jnci/djy173
• Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT Cite
  Hu C, Li M, Guo T, Wang S, Huang W, Yang K, et al. Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT. Phytomedicine. Elsevier BV; 2018; 58:152740 10.1016/j.phymed.2018.11.001
• Statin use and risk of contralateral breast cancer: a nationwide cohort study Cite
  Langballe R, Cronin-Fenton D, Dehlendorff C, Jensen M, Ejlertsen B, Andersson M, et al. Statin use and risk of contralateral breast cancer: a nationwide cohort study. British Journal of Cancer. Springer Science and Business Media LLC; 2018; 119:1297-1305 10.1038/s41416-018-0252-1
• 6,7,4′-Trihydroxyisoflavone suppressed the estrogen receptor negative breast cancer growth via regulating glycogen synthase kinase-3β/β-catenin signaling Cite
  Chen J, Lee J, Bao C, Kim JT, Lee HJ. 6,7,4′-Trihydroxyisoflavone suppressed the estrogen receptor negative breast cancer growth via regulating glycogen synthase kinase-3β/β-catenin signaling. Journal of Functional Foods. Elsevier BV; 2018; 48:498-506 10.1016/j.jff.2018.07.044
• Fruit and vegetable consumption and breast cancer incidence: Repeated measures over 30 years of follow‐up Cite
  Farvid MS, Chen WY, Rosner BA, Tamimi RM, Willett WC, Eliassen AH. Fruit and vegetable consumption and breast cancer incidence: Repeated measures over 30 years of follow‐up. International Journal of Cancer. Wiley; 2018; 144:1496-1510 10.1002/ijc.31653
• Use of dietary supplements in soy isoflavones and risk of breast cancer among women aged over 50 years: Results from the E3 N prospective cohort Cite
  Fournier A, Touillaud M, Gelot A, Mesrine S, Bennetau-Pelissero C, Boutron-Ruault M. Use of dietary supplements in soy isoflavones and risk of breast cancer among women aged over 50 years: Results from the E3 N prospective cohort. Revue d'Épidémiologie et de Santé Publique. Elsevier BV; 2018; 66:S285 10.1016/j.respe.2018.05.129
• Association of Body Mass Index and Age With Subsequent Breast Cancer Risk in Premenopausal Women Cite
  Schoemaker MJ, Nichols HB, Wright LB, Brook MN, Jones ME, O’Brien KM, et al. Association of Body Mass Index and Age With Subsequent Breast Cancer Risk in Premenopausal Women. JAMA Oncology. American Medical Association (AMA); 2018; 4:e181771 10.1001/jamaoncol.2018.1771
• Regulatory role of resveratrol, a microRNA-controlling compound, in HNRNPA1 expression, which is associated with poor prognosis in breast cancer Cite
  Otsuka K, Yamamoto Y, Ochiya T. Regulatory role of resveratrol, a microRNA-controlling compound, in HNRNPA1 expression, which is associated with poor prognosis in breast cancer. Oncotarget. Impact Journals, LLC; 2018; 9:24718-24730 10.18632/oncotarget.25339
• Meta-analysis of the association between the dietary inflammatory index (DII) and breast cancer risk Cite
  Wang L, Liu C, Zhou C, Zhuang J, Tang S, Yu J, et al. Meta-analysis of the association between the dietary inflammatory index (DII) and breast cancer risk. European Journal of Clinical Nutrition. Springer Science and Business Media LLC; 2018; 73:509-517 10.1038/s41430-018-0196-9
• Dairy Consumption in Adolescence and Early Adulthood and Risk of Breast Cancer Cite
  Farvid MS, Eliassen AH, Cho E, Chen WY, Willett WC. Dairy Consumption in Adolescence and Early Adulthood and Risk of Breast Cancer. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2018; 27:575-584 10.1158/1055-9965.epi-17-0345
• Pre-diagnostic changes in body mass index and mortality among breast cancer patients Cite
  Larsen SB, Torstensson M, Kenborg L, Christensen J, Kroman N, Dalton SO, et al. Pre-diagnostic changes in body mass index and mortality among breast cancer patients. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2018; 170:605-612 10.1007/s10549-018-4771-5
• Intake of bean fiber, beans, and grains and reduced risk of hormone receptor-negative breast cancer: the San Francisco Bay Area Breast Cancer Study Cite
  Sangaramoorthy M, Koo J, John EM. Intake of bean fiber, beans, and grains and reduced risk of hormone receptor-negative breast cancer: the San Francisco Bay Area Breast Cancer Study. Cancer Medicine. Wiley; 2018; 7:2131-2144 10.1002/cam4.1423
• Apigenin, a dietary flavonoid, induces apoptosis, DNA damage, and oxidative stress in human breast cancer MCF-7 and MDA MB-231 cells Cite
  Vrhovac Madunić I, Madunić J, Antunović M, Paradžik M, Garaj-Vrhovac V, Breljak D, et al. Apigenin, a dietary flavonoid, induces apoptosis, DNA damage, and oxidative stress in human breast cancer MCF-7 and MDA MB-231 cells. Naunyn-Schmiedeberg's Archives of Pharmacology. Springer Science and Business Media LLC; 2018; 391:537-550 10.1007/s00210-018-1486-4
• Oestrogen receptor negative early operable primary breast cancer in older women—Biological characteristics and long-term clinical outcome Cite
  Syed BM, Morgan D, Setty T, Green AR, Paish EC, Ellis IO, et al. Oestrogen receptor negative early operable primary breast cancer in older women—Biological characteristics and long-term clinical outcome. PLOS ONE. Public Library of Science (PLoS); 2017; 12:e0188528 10.1371/journal.pone.0188528
• Long-term survival outcomes of triple-receptor negative breast cancer survivors who are disease free at 5 years and relationship with low hormone receptor positivity Cite
  Reddy SM, Barcenas CH, Sinha AK, Hsu L, Moulder SL, Tripathy D, et al. Long-term survival outcomes of triple-receptor negative breast cancer survivors who are disease free at 5 years and relationship with low hormone receptor positivity. British Journal of Cancer. Springer Science and Business Media LLC; 2017; 118:17-23 10.1038/bjc.2017.379
• C-reactive protein binds to integrin α2 and Fcγ receptor I, leading to breast cell adhesion and breast cancer progression Cite
  Kim E, Kim SY, Koh M, Lee H, Kim K, Jung J, et al. C-reactive protein binds to integrin α2 and Fcγ receptor I, leading to breast cell adhesion and breast cancer progression. Oncogene. Springer Science and Business Media LLC; 2017; 37:28-38 10.1038/onc.2017.298
• Oxygen-dependent regulation of tumor growth and metastasis in human breast cancer xenografts Cite
  Yttersian Sletta K, Tveitarås MK, Lu N, Engelsen AST, Reed RK, Garmann-Johnsen A, et al. Oxygen-dependent regulation of tumor growth and metastasis in human breast cancer xenografts. PLOS ONE. Public Library of Science (PLoS); 2017; 12:e0183254 10.1371/journal.pone.0183254
• Active smoking and survival following breast cancer among African American and non-African American women in the Carolina Breast Cancer Study Cite
  Parada H, Sun X, Tse C, Olshan AF, Troester MA, Conway K. Active smoking and survival following breast cancer among African American and non-African American women in the Carolina Breast Cancer Study. Cancer Causes & Control. Springer Science and Business Media LLC; 2017; 28:929-938 10.1007/s10552-017-0923-x
• The impact of molecular subtype on breast cancer recurrence in young women treated with contemporary adjuvant therapy Cite
  Alabdulkareem H, Pinchinat T, Khan S, Landers A, Christos P, Simmons R, et al. The impact of molecular subtype on breast cancer recurrence in young women treated with contemporary adjuvant therapy. The Breast Journal. Wiley; 2017; 24:148-153 10.1111/tbj.12853
• Risk of mortality of node-negative, ER/PR/HER2 breast cancer subtypes in T1, T2, and T3 tumors Cite
  Parise CA, Caggiano V. Risk of mortality of node-negative, ER/PR/HER2 breast cancer subtypes in T1, T2, and T3 tumors. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 165:743-750 10.1007/s10549-017-4383-5
• Abstract 2305: Residential airborne heavy metal concentrations and breast cancer characteristics Cite
  Kresovich JK, Erdal S, Argos M, Chen HY, Gann PH, Rauscher GH. Abstract 2305: Residential airborne heavy metal concentrations and breast cancer characteristics. Epidemiology. American Association for Cancer Research; 2017; 10.1158/1538-7445.am2017-2305
• Radiation therapy utilization and outcomes for older women with breast cancer: Impact of molecular subtype and tumor grade Cite
  Haque W, Kee Yuan DM, Verma V, Butler EB, Teh BS, Wiederhold L, et al. Radiation therapy utilization and outcomes for older women with breast cancer: Impact of molecular subtype and tumor grade. The Breast. Elsevier BV; 2017; 35:34-41 10.1016/j.breast.2017.06.011
• The prognostic effect of estrogen receptor status differs for younger versus older breast cancer patients Cite
  Sopik V, Sun P, Narod SA. The prognostic effect of estrogen receptor status differs for younger versus older breast cancer patients. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 165:391-402 10.1007/s10549-017-4333-2
• Pretreatment Serum Concentration of Vitamin D and Breast Cancer Characteristics: A Prospective Observational Mediterranean Study Cite
  Buono G, Giuliano M, De Angelis C, Lauria R, Forestieri V, Pensabene M, et al. Pretreatment Serum Concentration of Vitamin D and Breast Cancer Characteristics: A Prospective Observational Mediterranean Study. Clinical Breast Cancer. Elsevier BV; 2017; 17:559-563 10.1016/j.clbc.2017.05.007
• Breast cancer subtypes predict the preferential site of distant metastases: a SEER based study Cite
  Wu Q, Li J, Zhu S, Wu J, Chen C, Liu Q, et al. Breast cancer subtypes predict the preferential site of distant metastases: a SEER based study. Oncotarget. Impact Journals, LLC; 2017; 8:27990-27996 10.18632/oncotarget.15856
• Abstract B40: [10]-gingerol as a pro-apoptotic molecule in triple negative breast cancer Cite
  Martin ACBM, Tomasin R, Becceneri AB, Fuzer A, Vieira PC, Cominetti MR. Abstract B40: [10]-gingerol as a pro-apoptotic molecule in triple negative breast cancer. Exploiting Repair Defects in the Tumor Microenvironment. American Association for Cancer Research; 2017; 10.1158/1557-3125.dnarepair16-b40
• Dietary isoflavone intake and all-cause mortality in breast cancer survivors: The Breast Cancer Family Registry Cite
  Zhang FF, Haslam DE, Terry MB, Knight JA, Andrulis IL, Daly MB, et al. Dietary isoflavone intake and all-cause mortality in breast cancer survivors: The Breast Cancer Family Registry. Cancer. Wiley; 2017; 123:2070-2079 10.1002/cncr.30615
• Mediterranean diet adherence and risk of postmenopausal breast cancer: results of a cohort study and meta-analysis Cite
  van den Brandt PA, Schulpen M. Mediterranean diet adherence and risk of postmenopausal breast cancer: results of a cohort study and meta-analysis. International Journal of Cancer. Wiley; 2017; 140:2220-2231 10.1002/ijc.30654
• Antitumor effects of naturally occurring cardiac glycosides convallatoxin and peruvoside on human ER+ and triple-negative breast cancers Cite
  Kaushik V, Azad N, Yakisich JS, Iyer AKV. Antitumor effects of naturally occurring cardiac glycosides convallatoxin and peruvoside on human ER+ and triple-negative breast cancers. Cell Death Discovery. Springer Science and Business Media LLC; 2017; 3 10.1038/cddiscovery.2017.9
• Ursolic acid-mediated changes in glycolytic pathway promote cytotoxic autophagy and apoptosis in phenotypically different breast cancer cells Cite
  Lewinska A, Adamczyk-Grochala J, Kwasniewicz E, Deregowska A, Wnuk M. Ursolic acid-mediated changes in glycolytic pathway promote cytotoxic autophagy and apoptosis in phenotypically different breast cancer cells. Apoptosis. Springer Science and Business Media LLC; 2017; 22:800-815 10.1007/s10495-017-1353-7
• Evidence of PKC Binding and Translocation to Explain the Anticancer Mechanism of Chlorogenic Acid in Breast Cancer Cells Cite
  Deka S, Gorai S, Manna D, Trivedi V. Evidence of PKC Binding and Translocation to Explain the Anticancer Mechanism of Chlorogenic Acid in Breast Cancer Cells. Current Molecular Medicine. Bentham Science Publishers Ltd.; 2017; 17:79-89 10.2174/1566524017666170209160619
• Diallyl trisulfide, a chemopreventive agent from Allium vegetables, inhibits alpha-secretases in breast cancer cells Cite
  Kiesel VA, Stan SD. Diallyl trisulfide, a chemopreventive agent from Allium vegetables, inhibits alpha-secretases in breast cancer cells. Biochemical and Biophysical Research Communications. Elsevier BV; 2017; 484:833-838 10.1016/j.bbrc.2017.01.184
• 27-Hydroxycholesterol induces invasion and migration of breast cancer cells by increasing MMP9 and generating EMT through activation of STAT-3 Cite
  Shen Z, Zhu D, Liu J, Chen J, Liu Y, Hu C, et al. 27-Hydroxycholesterol induces invasion and migration of breast cancer cells by increasing MMP9 and generating EMT through activation of STAT-3. Environmental Toxicology and Pharmacology. Elsevier BV; 2017; 51:1-8 10.1016/j.etap.2017.02.001
• Elevated Serum Levels of Retinol-Binding Protein 4 Are Associated with Breast Cancer Risk: A Case-Control Study Cite
  Jiao C, Cui L, Ma A, Li N, Si H. Elevated Serum Levels of Retinol-Binding Protein 4 Are Associated with Breast Cancer Risk: A Case-Control Study. PLOS ONE. Public Library of Science (PLoS); 2016; 11:e0167498 10.1371/journal.pone.0167498
• Risk Factors That Increase Risk of Estrogen Receptor–Positive and –Negative Breast Cancer Cite
  Kerlikowske K, Gard CC, Tice JA, Ziv E, Cummings SR, Miglioretti DL. Risk Factors That Increase Risk of Estrogen Receptor–Positive and –Negative Breast Cancer. Journal of the National Cancer Institute. Oxford University Press (OUP); 2016; 109:djw276 10.1093/jnci/djw276
• Adjuvant Radiation Improves Survival in Older Women Following Breast-Conserving Surgery for Estrogen Receptor–Negative Breast Cancer Cite
  Daugherty EC, Daugherty MR, Bogart JA, Shapiro A. Adjuvant Radiation Improves Survival in Older Women Following Breast-Conserving Surgery for Estrogen Receptor–Negative Breast Cancer. Clinical Breast Cancer. Elsevier BV; 2016; 16:500-506.e2 10.1016/j.clbc.2016.06.017
• Chemotherapy response and survival of inflammatory breast cancer by hormone receptor- and HER2-defined molecular subtypes approximation: an analysis from the National Cancer Database Cite
  Liu J, Chen K, Jiang W, Mao K, Li S, Kim MJ, et al. Chemotherapy response and survival of inflammatory breast cancer by hormone receptor- and HER2-defined molecular subtypes approximation: an analysis from the National Cancer Database. Journal of Cancer Research and Clinical Oncology. Springer Science and Business Media LLC; 2016; 143:161-168 10.1007/s00432-016-2281-6
• The Circadian Rhythm Gene Arntl2 Is a Metastasis Susceptibility Gene for Estrogen Receptor-Negative Breast Cancer Cite
  Ha N, Long J, Cai Q, Shu XO, Hunter KW. The Circadian Rhythm Gene Arntl2 Is a Metastasis Susceptibility Gene for Estrogen Receptor-Negative Breast Cancer. PLOS Genetics. Public Library of Science (PLoS); 2016; 12:e1006267 10.1371/journal.pgen.1006267
• Differential pro-apoptotic effect of allicin in oestrogen receptor-positive or -negative human breast cancer cells Cite
  Kim K, Cho S, Kim B, Pyo S. Differential pro-apoptotic effect of allicin in oestrogen receptor-positive or -negative human breast cancer cells. Journal of Functional Foods. Elsevier BV; 2016; 25:341-353 10.1016/j.jff.2016.06.019
• Early versus late distant metastasis and adjuvant chemotherapy alone versus both radiotherapy and chemotherapy in molecular apocrine breast cancer Cite
  Liu X, Yang Y, Feng X, Shen H, Liu J, Liu X, et al. Early versus late distant metastasis and adjuvant chemotherapy alone versus both radiotherapy and chemotherapy in molecular apocrine breast cancer. Oncotarget. Impact Journals, LLC; 2016; 7:48905-48917 10.18632/oncotarget.10211
• Adjuvant Radiation Improves Survival in Older Women Following Breast-Conserving Surgery for Estrogen Receptor–Negative Breast Cancer Cite
  Daugherty EC, Daugherty MR, Bogart JA, Shapiro A. Adjuvant Radiation Improves Survival in Older Women Following Breast-Conserving Surgery for Estrogen Receptor–Negative Breast Cancer. Clinical Breast Cancer. Elsevier BV; 2016; 16:500-506.e2 10.1016/j.clbc.2016.06.017
• Effects of letrozole on breast cancer micro-metastatic tumor growth in bone and lung in mice inoculated with murine 4T1 cells Cite
  Wang W, Belosay A, Yang X, Hartman JA, Song H, Iwaniec UT, et al. Effects of letrozole on breast cancer micro-metastatic tumor growth in bone and lung in mice inoculated with murine 4T1 cells. Clinical & Experimental Metastasis. Springer Science and Business Media LLC; 2016; 33:475-485 10.1007/s10585-016-9792-z
• Resveratrol inhibits cell cycle progression by targeting Aurora kinase A and Polo-like kinase 1 in breast cancer cells Cite
  MEDINA-AGUILAR R, MARCHAT LA, OCAMPO EA, GARIGLIO P, MENA JG, SEPÚLVEDA NV, et al. Resveratrol inhibits cell cycle progression by targeting Aurora kinase A and Polo-like kinase 1 in breast cancer cells. Oncology Reports. Spandidos Publications; 2016; 35:3696-3704 10.3892/or.2016.4728
• Abstract C49: Relation of family history of cancer to risk of ER+, ER-, and triple-negative breast cancer in African American women Cite
  Bethea TN, Rosenberg L, Castro-Webb N, Lunetta KL, Sucheston LE, Ruiz-Narvaez EA, et al. Abstract C49: Relation of family history of cancer to risk of ER+, ER-, and triple-negative breast cancer in African American women. Organ Site Research. American Association for Cancer Research; 2016; 10.1158/1538-7755.disp15-c49
• Abstract C51: Ethnic differences in the relationship between diabetes, early age adiposity, and mortality among breast cancer survivors: The Breast Cancer Health Disparities Study Cite
  Connor AE, Visvanathan K, Baumgartner KB, Baumgartner RN, Boone SD, Hines LM, et al. Abstract C51: Ethnic differences in the relationship between diabetes, early age adiposity, and mortality among breast cancer survivors: The Breast Cancer Health Disparities Study. Organ Site Research. American Association for Cancer Research; 2016; 10.1158/1538-7755.disp15-c51
• Allyl Isothiocyanate Induces Cell Toxicity by Multiple Pathways in Human Breast Cancer Cells Cite
  Bo P, Lien J, Chen Y, Yu F, Lu H, Yu C, et al. Allyl Isothiocyanate Induces Cell Toxicity by Multiple Pathways in Human Breast Cancer Cells. The American Journal of Chinese Medicine. World Scientific Pub Co Pte Lt; 2016; 44:415-437 10.1142/s0192415x16500245
• The association of soy food consumption with the risk of subtype of breast cancers defined by hormone receptor and HER2 status Cite
  Baglia ML, Zheng W, Li H, Yang G, Gao J, Gao Y, et al. The association of soy food consumption with the risk of subtype of breast cancers defined by hormone receptor and HER2 status. International Journal of Cancer. Wiley; 2016; 139:742-748 10.1002/ijc.30117
• Caffeic Acid Phenethyl Ester Increases Radiosensitivity of Estrogen Receptor-Positive and -Negative Breast Cancer Cells by Prolonging Radiation-Induced DNA Damage Cite
  Khoram NM, Bigdeli B, Nikoofar A, Goliaei B. Caffeic Acid Phenethyl Ester Increases Radiosensitivity of Estrogen Receptor-Positive and -Negative Breast Cancer Cells by Prolonging Radiation-Induced DNA Damage. Journal of Breast Cancer. Korean Breast Cancer Society; 2016; 19:18 10.4048/jbc.2016.19.1.18
• Biological Subtype Predicts Risk of Locoregional Recurrence After Mastectomy and Impact of Postmastectomy Radiation in a Large National Database Cite
  Tseng YD, Uno H, Hughes ME, Niland JC, Wong Y, Theriault R, et al. Biological Subtype Predicts Risk of Locoregional Recurrence After Mastectomy and Impact of Postmastectomy Radiation in a Large National Database. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2015; 93:622-630 10.1016/j.ijrobp.2015.07.006
• Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V Cite
  Colleoni M, Sun Z, Price KN, Karlsson P, Forbes JF, Thürlimann B, et al. Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2016; 34:927-935 10.1200/jco.2015.62.3504
• Plasma carotenoids, vitamin C, tocopherols, and retinol and the risk of breast cancer in the European Prospective Investigation into Cancer and Nutrition cohort1,2 Cite
  Bakker MF, Peeters PH, Klaasen VM, Bueno-de-Mesquita HB, Jansen EH, Ros MM, et al. Plasma carotenoids, vitamin C, tocopherols, and retinol and the risk of breast cancer in the European Prospective Investigation into Cancer and Nutrition cohort1,2. The American Journal of Clinical Nutrition. Oxford University Press (OUP); 2016; 103:454-464 10.3945/ajcn.114.101659
• Genistein-induced differentiation of breast cancer stem/progenitor cells through a paracrine mechanism Cite
  LIU Y, ZOU T, WANG S, CHEN H, SU D, FU X, et al. Genistein-induced differentiation of breast cancer stem/progenitor cells through a paracrine mechanism. International Journal of Oncology. Spandidos Publications; 2016; 48:1063-1072 10.3892/ijo.2016.3351
• Androgen receptor expression predicts beneficial tamoxifen response in oestrogen receptor-α-negative breast cancer Cite
  Hilborn E, Gacic J, Fornander T, Nordenskjöld B, Stål O, Jansson A. Androgen receptor expression predicts beneficial tamoxifen response in oestrogen receptor-α-negative breast cancer. British Journal of Cancer. Springer Science and Business Media LLC; 2016; 114:248-255 10.1038/bjc.2015.464
• Reproductive factors, tumor estrogen receptor status and contralateral breast cancer risk: results from the WECARE study Cite
  Sisti JS, Bernstein JL, Lynch CF, Reiner AS, Mellemkjaer L, Brooks JD, et al. Reproductive factors, tumor estrogen receptor status and contralateral breast cancer risk: results from the WECARE study. SpringerPlus. Springer Science and Business Media LLC; 2015; 4 10.1186/s40064-015-1642-y
• Cytologic atypia in the contralateral unaffected breast is related to parity and estrogen-related genes Cite
  Monahan DA, Wang J, Lee O, Revesz E, Taft N, Ivancic D, et al. Cytologic atypia in the contralateral unaffected breast is related to parity and estrogen-related genes. Surgical Oncology. Elsevier BV; 2016; 25:449-456 10.1016/j.suronc.2015.12.001
• The Association of Low-To-Moderate Alcohol Consumption with Breast Cancer Subtypes Defined by Hormone Receptor Status Cite
  Strumylaite L, Sharp SJ, Kregzdyte R, Poskiene L, Bogusevicius A, Pranys D. The Association of Low-To-Moderate Alcohol Consumption with Breast Cancer Subtypes Defined by Hormone Receptor Status. PLOS ONE. Public Library of Science (PLoS); 2015; 10:e0144680 10.1371/journal.pone.0144680
• Digitoxin enhances the growth inhibitory effects of thapsigargin and simvastatin on ER negative human breast cancer cells Cite
  Einbond LS, Wu H, Sandu C, Ford M, Mighty J, Antonetti V, et al. Digitoxin enhances the growth inhibitory effects of thapsigargin and simvastatin on ER negative human breast cancer cells. Fitoterapia. Elsevier BV; 2016; 109:146-154 10.1016/j.fitote.2015.12.005
• Long-term survival and stage I breast cancer subtypes Cite
  Cheng SH, Yu B, Horng C, Tsai SY, Chen C, Chu N, et al. Long-term survival and stage I breast cancer subtypes. Journal of Cancer Research and Practice. Medknow; 2016; 3:1-8 10.1016/j.jcrpr.2015.10.005
• Vegetable and fruit consumption and the risk of hormone receptor–defined breast cancer in the EPIC cohort Cite
  Emaus MJ, Peeters PH, Bakker MF, Overvad K, Tjønneland A, Olsen A, et al. Vegetable and fruit consumption and the risk of hormone receptor–defined breast cancer in the EPIC cohort. The American Journal of Clinical Nutrition. Oxford University Press (OUP); 2015; 103:168-177 10.3945/ajcn.114.101436
• Breastfeeding and breast cancer risk by receptor status—a systematic review and meta-analysis Cite
  Islami F, Liu Y, Jemal A, Zhou J, Weiderpass E, Colditz G, et al. Breastfeeding and breast cancer risk by receptor status—a systematic review and meta-analysis. Annals of Oncology. Elsevier BV; 2015; 26:2398-2407 10.1093/annonc/mdv379
• Inhibitory Effects of Enterolactone on Growth and Metastasis in Human Breast Cancer Cite
  Xiong X, Hu X, Li Y, Liu C. Inhibitory Effects of Enterolactone on Growth and Metastasis in Human Breast Cancer. Nutrition and Cancer. Informa UK Limited; 2015; 67:1326-1334 10.1080/01635581.2015.1082113
• Piperlongumine for Enhancing Oral Bioavailability and Cytotoxicity of Docetaxel in Triple-Negative Breast Cancer Cite
  Patel K, Chowdhury N, Doddapaneni R, Boakye CH, Godugu C, Singh M. Piperlongumine for Enhancing Oral Bioavailability and Cytotoxicity of Docetaxel in Triple-Negative Breast Cancer. Journal of Pharmaceutical Sciences. Elsevier BV; 2015; 104:4417-4426 10.1002/jps.24637
• Important Role of Menarche in Development of Estrogen Receptor–Negative Breast Cancer in African American Women Cite
  Ambrosone CB, Zirpoli G, Hong C, Yao S, Troester MA, Bandera EV, et al. Important Role of Menarche in Development of Estrogen Receptor–Negative Breast Cancer in African American Women. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2015; 107 10.1093/jnci/djv172
• Comparison of the Genomic Landscape Between Primary Breast Cancer in African American Versus White Women and the Association of Racial Differences With Tumor Recurrence Cite
  Keenan T, Moy B, Mroz EA, Ross K, Niemierko A, Rocco JW, et al. Comparison of the Genomic Landscape Between Primary Breast Cancer in African American Versus White Women and the Association of Racial Differences With Tumor Recurrence. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015; 33:3621-3627 10.1200/jco.2015.62.2126
• Modifiable Lifestyle Factors and Triple-negative Breast Cancer Survival Cite
  Bao P, Zhao G, Shu X, Peng P, Cai H, Lu W, et al. Modifiable Lifestyle Factors and Triple-negative Breast Cancer Survival. Epidemiology. Ovid Technologies (Wolters Kluwer Health); 2015; 26:909-916 10.1097/ede.0000000000000373
• Bisphenol A stimulates the epithelial mesenchymal transition of estrogen negative breast cancer cells via FOXA1 signals Cite
  Zhang X, Wang H, Liu N, Ge L. Bisphenol A stimulates the epithelial mesenchymal transition of estrogen negative breast cancer cells via FOXA1 signals. Archives of Biochemistry and Biophysics. Elsevier BV; 2015; 585:10-16 10.1016/j.abb.2015.09.006
• Differential Ratios of Omega Fatty Acids (AA/EPA+DHA) Modulate Growth, Lipid Peroxidation and Expression of Tumor Regulatory MARBPs in Breast Cancer Cell Lines MCF7 and MDA-MB-231 Cite
  Mansara PP, Deshpande RA, Vaidya MM, Kaul-Ghanekar R. Differential Ratios of Omega Fatty Acids (AA/EPA+DHA) Modulate Growth, Lipid Peroxidation and Expression of Tumor Regulatory MARBPs in Breast Cancer Cell Lines MCF7 and MDA-MB-231. PLOS ONE. Public Library of Science (PLoS); 2015; 10:e0136542 10.1371/journal.pone.0136542
• Effect of aluminium on migration of oestrogen unresponsive MDA-MB-231 human breast cancer cells in culture Cite
  Bakir A, Darbre PD. Effect of aluminium on migration of oestrogen unresponsive MDA-MB-231 human breast cancer cells in culture. Journal of Inorganic Biochemistry. Elsevier BV; 2015; 152:180-185 10.1016/j.jinorgbio.2015.09.001
• The garlic compound ajoene targets protein folding in the endoplasmic reticulum of cancer cells Cite
  Kaschula CH, Hunter R, Cotton J, Tuveri R, Ngarande E, Dzobo K, et al. The garlic compound ajoene targets protein folding in the endoplasmic reticulum of cancer cells. Molecular Carcinogenesis. Wiley; 2015; 55:1213-1228 10.1002/mc.22364
• Altering the tumor microenvironment: A phase II study of copper depletion using tetrathiomolybdate (TM) in patients (pts) with breast cancer (BC) at high risk for recurrence. Cite
  Nackos EN, Kornhauser N, Ward MM, Cigler T, Moore A, Andreopoulou E, et al. Altering the tumor microenvironment: A phase II study of copper depletion using tetrathiomolybdate (TM) in patients (pts) with breast cancer (BC) at high risk for recurrence.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015; 33:11008-11008 10.1200/jco.2015.33.15_suppl.11008
• Breast Cancer Subtype as a Predictor of Lymph Node Metastasis according to the SEER Registry Cite
  Mattes MD, Bhatia JK, Metzger D, Ashamalla H, Katsoulakis E. Breast Cancer Subtype as a Predictor of Lymph Node Metastasis according to the SEER Registry. Journal of Breast Cancer. Korean Breast Cancer Society; 2015; 18:143 10.4048/jbc.2015.18.2.143
• Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients Cite
  Ricciardi GRR, Adamo B, Ieni A, Licata L, Cardia R, Ferraro G, et al. Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients. PLOS ONE. Public Library of Science (PLoS); 2015; 10:e0128368 10.1371/journal.pone.0128368
• Age-Related Disparity in Immediate Prognosis of Patients with Triple-Negative Breast Cancer: A Population-Based Study from SEER Cancer Registries Cite
  Zhu W, Perez EA, Hong R, Li Q, Xu B. Age-Related Disparity in Immediate Prognosis of Patients with Triple-Negative Breast Cancer: A Population-Based Study from SEER Cancer Registries. PLOS ONE. Public Library of Science (PLoS); 2015; 10:e0128345 10.1371/journal.pone.0128345
• Lower Breast Cancer Risk among Women following the World Cancer Research Fund and American Institute for Cancer Research Lifestyle Recommendations: EpiGEICAM Case-Control Study Cite
  Castelló A, Martín M, Ruiz A, Casas AM, Baena-Cañada JM, Lope V, et al. Lower Breast Cancer Risk among Women following the World Cancer Research Fund and American Institute for Cancer Research Lifestyle Recommendations: EpiGEICAM Case-Control Study. PLOS ONE. Public Library of Science (PLoS); 2015; 10:e0126096 10.1371/journal.pone.0126096
• Abstract 913: Natural product sulforaphane selectively inhibits breast cancer stem cells in basal and trastuzumab resistant Her2+ breast cancer. Cite
  Burnett J, Korkaya H, Newman B, Conley S, Connarn J, Sun L, et al. Abstract 913: Natural product sulforaphane selectively inhibits breast cancer stem cells in basal and trastuzumab resistant Her2+ breast cancer.. Experimental and Molecular Therapeutics. American Association for Cancer Research; 2013; 10.1158/1538-7445.am2013-913
• Melatonin Regulates Angiogenic Factors under Hypoxia in Breast Cancer Cell Lines Cite
  Victorasso Jardim-Perassi B, Repolês Lourenço M, Mandarini Doho G, Helen Grígolo I, Bottaro Gelaleti G, Carvalho Ferreira L, et al. Melatonin Regulates Angiogenic Factors under Hypoxia in Breast Cancer Cell Lines. Anti-Cancer Agents in Medicinal Chemistry. Bentham Science Publishers Ltd.; 2016; 16:347-358 10.2174/1871520615666150511094201
• Abstract P5-05-13: Obesity confers chemotherapy resistance in triple negative breast cancer cells Cite
  Lehrmann VR, Bowers LW, Brenner AJ, deGraffenried LA. Abstract P5-05-13: Obesity confers chemotherapy resistance in triple negative breast cancer cells. Poster Session Abstracts. American Association for Cancer Research; 2015; 10.1158/1538-7445.sabcs14-p5-05-13
• Abstract P6-04-01: Melatonin on angiogenesis in breast cancer Cite
  Zuccari DC, Jardim-Perassi BV, Lourenço MR, Doho GM, Gelaleti GB, Ferreira LC, et al. Abstract P6-04-01: Melatonin on angiogenesis in breast cancer. Poster Session Abstracts. American Association for Cancer Research; 2015; 10.1158/1538-7445.sabcs14-p6-04-01
• Antimetastatic Therapies of the Polysulfide Diallyl Trisulfide against Triple-Negative Breast Cancer (TNBC) via Suppressing MMP2/9 by Blocking NF-κB and ERK/MAPK Signaling Pathways Cite
  Liu Y, Zhu P, Wang Y, Wei Z, Tao L, Zhu Z, et al. Antimetastatic Therapies of the Polysulfide Diallyl Trisulfide against Triple-Negative Breast Cancer (TNBC) via Suppressing MMP2/9 by Blocking NF-κB and ERK/MAPK Signaling Pathways. PLOS ONE. Public Library of Science (PLoS); 2015; 10:e0123781 10.1371/journal.pone.0123781
• Energy-Related Indicators and Breast Cancer Risk among White and Black Women Cite
  Sanderson M, Lipworth L, Shen-Miller D, Nechuta S, Beeghly-Fadiel A, Shrubsole MJ, et al. Energy-Related Indicators and Breast Cancer Risk among White and Black Women. PLOS ONE. Public Library of Science (PLoS); 2015; 10:e0125058 10.1371/journal.pone.0125058
• Stress hormones reduce the efficacy of paclitaxel in triple negative breast cancer through induction of DNA damage Cite
  Reeder A, Attar M, Nazario L, Bathula C, Zhang A, Hochbaum D, et al. Stress hormones reduce the efficacy of paclitaxel in triple negative breast cancer through induction of DNA damage. British Journal of Cancer. Springer Science and Business Media LLC; 2015; 112:1461-1470 10.1038/bjc.2015.133
• Docosahexaenoic acid inhibits the invasion of MDA-MB-231 breast cancer cells through upregulation of cytokeratin-1 Cite
  BLANCKAERT V, KERVIEL V, LÉPINAY A, JOUBERT-DURIGNEUX V, HONDERMARCK H, CHÉNAIS B. Docosahexaenoic acid inhibits the invasion of MDA-MB-231 breast cancer cells through upregulation of cytokeratin-1. International Journal of Oncology. Spandidos Publications; 2015; 46:2649-2655 10.3892/ijo.2015.2936
• Predictive Significance of p53, Ki-67, and Bcl-2 Expression for Pathologic Complete Response after Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer Cite
  Kim T, Han W, Kim MK, Lee JW, Kim J, Ahn SK, et al. Predictive Significance of p53, Ki-67, and Bcl-2 Expression for Pathologic Complete Response after Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer. Journal of Breast Cancer. Korean Breast Cancer Society; 2015; 18:16 10.4048/jbc.2015.18.1.16
• Short-term weight gain and breast cancer risk by hormone receptor classification among pre- and postmenopausal women Cite
  Rosner B, Eliassen AH, Toriola AT, Hankinson SE, Willett WC, Natarajan L, et al. Short-term weight gain and breast cancer risk by hormone receptor classification among pre- and postmenopausal women. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2015; 150:643-653 10.1007/s10549-015-3344-0
• Hormone Receptor Status and HER2 Expression in Primary Breast Cancer Compared With Synchronous Axillary Metastases or Recurrent Metastatic Disease Cite
  Rossi S, Basso M, Strippoli A, Dadduzio V, Cerchiaro E, Barile R, et al. Hormone Receptor Status and HER2 Expression in Primary Breast Cancer Compared With Synchronous Axillary Metastases or Recurrent Metastatic Disease. Clinical Breast Cancer. Elsevier BV; 2015; 15:307-312 10.1016/j.clbc.2015.03.010
• Clinical and molecular characteristics of triple-negative breast cancer patients in Northern Israel: single center experience Cite
  Asleh-Aburaya K, Fried G. Clinical and molecular characteristics of triple-negative breast cancer patients in Northern Israel: single center experience. SpringerPlus. Springer Science and Business Media LLC; 2015; 4 10.1186/s40064-015-0900-3
• Prevalence of BRCA1 mutations and responses to neoadjuvant chemotherapy among BRCA1 carriers and non-carriers with triple-negative breast cancer Cite
  Wang C, Zhang J, Wang Y, Ouyang T, Li J, Wang T, et al. Prevalence of BRCA1 mutations and responses to neoadjuvant chemotherapy among BRCA1 carriers and non-carriers with triple-negative breast cancer. Annals of Oncology. Elsevier BV; 2015; 26:523-528 10.1093/annonc/mdu559
• Elevated risks of subsequent endometrial cancer development among breast cancer survivors with different hormone receptor status: a SEER analysis Cite
  Liu J, Jiang W, Mao K, An Y, Su F, Kim BYS, et al. Elevated risks of subsequent endometrial cancer development among breast cancer survivors with different hormone receptor status: a SEER analysis. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2015; 150:439-445 10.1007/s10549-015-3315-5
• Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition Cite
  Su C, Lee W, Wu AT, Lin Y, Wang L, Wu C, et al. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition. The Journal of Nutritional Biochemistry. Elsevier BV; 2015; 26:675-685 10.1016/j.jnutbio.2015.01.005
• Radiation therapy in the locoregional treatment of triple-negative breast cancer Cite
  Moran MS. Radiation therapy in the locoregional treatment of triple-negative breast cancer. The Lancet Oncology. Elsevier BV; 2015; 16:e113-e122 10.1016/s1470-2045(14)71104-0
• The role of polycomb group protein Bmi-1 and Notch4 in breast cancer stem cell inhibition by benzyl isothiocyanate Cite
  Kim S, Singh SV. The role of polycomb group protein Bmi-1 and Notch4 in breast cancer stem cell inhibition by benzyl isothiocyanate. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2015; 149:681-692 10.1007/s10549-015-3279-5
• Coffee and tea consumption and risk of pre- and postmenopausal breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort study Cite
  Bhoo-Pathy N, Peeters PH, Uiterwaal CS, Bueno-de-Mesquita HB, Bulgiba AM, Bech BH, et al. Coffee and tea consumption and risk of pre- and postmenopausal breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort study. Breast Cancer Research. Springer Science and Business Media LLC; 2015; 17 10.1186/s13058-015-0521-3
• Pattern of metastasis and outcome in patients with breast cancer Cite
  Gerratana L, Fanotto V, Bonotto M, Bolzonello S, Minisini AM, Fasola G, et al. Pattern of metastasis and outcome in patients with breast cancer. Clinical & Experimental Metastasis. Springer Science and Business Media LLC; 2015; 32:125-133 10.1007/s10585-015-9697-2
• Silibinin affects tumor cell growth because of reduction of stemness properties and induction of apoptosis in 2D and 3D models of MDA-MB-468 Cite
  Abdollahi P, Ebrahimi M, Motamed N, Samani FS. Silibinin affects tumor cell growth because of reduction of stemness properties and induction of apoptosis in 2D and 3D models of MDA-MB-468. Anti-Cancer Drugs. Ovid Technologies (Wolters Kluwer Health); 2015; 26:487-497 10.1097/cad.0000000000000205
• Evaluation of In Vitro Anticancer Activity of Ocimum Basilicum, Alhagi Maurorum, Calendula Officinalis and Their Parasite Cuscuta Campestris Cite
  Behbahani M. Evaluation of In Vitro Anticancer Activity of Ocimum Basilicum, Alhagi Maurorum, Calendula Officinalis and Their Parasite Cuscuta Campestris. PLoS ONE. Public Library of Science (PLoS); 2014; 9:e116049 10.1371/journal.pone.0116049
• A Novel Triterpenoid Isolated from Apple Functions as an Anti-mammary Tumor Agent via a Mitochondrial and Caspase-Independent Apoptosis Pathway Cite
  Qiao A, Wang Y, Xiang L, Wang C, He X. A Novel Triterpenoid Isolated from Apple Functions as an Anti-mammary Tumor Agent via a Mitochondrial and Caspase-Independent Apoptosis Pathway. Journal of Agricultural and Food Chemistry. American Chemical Society (ACS); 2014; 63:185-191 10.1021/jf5053546
• Evolution of Genetic Testing for Inherited Susceptibility to Breast Cancer Cite
  Domchek SM. Evolution of Genetic Testing for Inherited Susceptibility to Breast Cancer. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015; 33:295-296 10.1200/jco.2014.59.3178
• Advanced glycation endproducts increase proliferation, migration and invasion of the breast cancer cell line MDA-MB-231 Cite
  Sharaf H, Matou-Nasri S, Wang Q, Rabhan Z, Al-Eidi H, Al Abdulrahman A, et al. Advanced glycation endproducts increase proliferation, migration and invasion of the breast cancer cell line MDA-MB-231. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. Elsevier BV; 2015; 1852:429-441 10.1016/j.bbadis.2014.12.009
• Association of Genetic Ancestry with Breast Cancer in Ethnically Diverse Women from Chicago Cite
  Al-Alem U, Rauscher G, Shah E, Batai K, Mahmoud A, Beisner E, et al. Association of Genetic Ancestry with Breast Cancer in Ethnically Diverse Women from Chicago. PLoS ONE. Public Library of Science (PLoS); 2014; 9:e112916 10.1371/journal.pone.0112916
• Dietary Folate Intake and Breast Cancer Risk: European Prospective Investigation Into Cancer and Nutrition Cite
  de Batlle J, Ferrari P, Chajes V, Park JY, Slimani N, McKenzie F, et al. Dietary Folate Intake and Breast Cancer Risk: European Prospective Investigation Into Cancer and Nutrition. JNCI Journal of the National Cancer Institute. Oxford University Press (OUP); 2014; 107:dju367-dju367 10.1093/jnci/dju367
• Older Patients With Early-stage Breast Cancer Cite
  Nagar H, Yan W, Christos P, Chao KC, Nori D, Ravi A. Older Patients With Early-stage Breast Cancer. American Journal of Clinical Oncology. Ovid Technologies (Wolters Kluwer Health); 2017; 40:300-305 10.1097/coc.0000000000000144
• Epidemiology, biology, and treatment of triple-negative breast cancer in women of African ancestry Cite
  Brewster AM, Chavez-MacGregor M, Brown P. Epidemiology, biology, and treatment of triple-negative breast cancer in women of African ancestry. The Lancet Oncology. Elsevier BV; 2014; 15:e625-e634 10.1016/s1470-2045(14)70364-x
• Diallyl Disulfide Suppresses SRC/Ras/ERK Signaling-Mediated Proliferation and Metastasis in Human Breast Cancer by Up-Regulating miR-34a Cite
  Xiao X, Chen B, Liu X, Liu P, Zheng G, Ye F, et al. Diallyl Disulfide Suppresses SRC/Ras/ERK Signaling-Mediated Proliferation and Metastasis in Human Breast Cancer by Up-Regulating miR-34a. PLoS ONE. Public Library of Science (PLoS); 2014; 9:e112720 10.1371/journal.pone.0112720
• Inhibitory effects of ginseng sapogenins on the proliferation of triple negative breast cancer MDA-MB-231 cells Cite
  Kwak JH, Park JY, Lee D, Kwak JY, Park EH, Kim KH, et al. Inhibitory effects of ginseng sapogenins on the proliferation of triple negative breast cancer MDA-MB-231 cells. Bioorganic & Medicinal Chemistry Letters. Elsevier BV; 2014; 24:5409-5412 10.1016/j.bmcl.2014.10.041
• Piperine inhibits the growth and motility of triple-negative breast cancer cells Cite
  Greenshields AL, Doucette CD, Sutton KM, Madera L, Annan H, Yaffe PB, et al. Piperine inhibits the growth and motility of triple-negative breast cancer cells. Cancer Letters. Elsevier BV; 2015; 357:129-140 10.1016/j.canlet.2014.11.017
• Abstract 1011: Metformin inhibits angiogenesis, local and metastatic growth of triple-negative breast cancer by targeting two classes of adipose tissue progenitors Cite
  Orecchioni S, Gregato G, Reggiani F, Mancuso P, Calleri A, Talarico G, et al. Abstract 1011: Metformin inhibits angiogenesis, local and metastatic growth of triple-negative breast cancer by targeting two classes of adipose tissue progenitors. Tumor Biology. American Association for Cancer Research; 2014; 10.1158/1538-7445.am2014-1011
• Anticancer effect of silibinin on the xenograft model using MDA-MB-468 breast cancer cells Cite
  Kil WH, Kim SM, Lee JE, Park KS, Nam SJ. Anticancer effect of silibinin on the xenograft model using MDA-MB-468 breast cancer cells. Annals of Surgical Treatment and Research. The Korean Surgical Society; 2014; 87:167 10.4174/astr.2014.87.4.167
• Cytotoxic Effects of Ellagitannins Isolated from Walnuts in Human Cancer Cells Cite
  Le V, Esposito D, Grace MH, Ha D, Pham A, Bortolazzo A, et al. Cytotoxic Effects of Ellagitannins Isolated from Walnuts in Human Cancer Cells. Nutrition and Cancer. Informa UK Limited; 2014; 66:1304-1314 10.1080/01635581.2014.956246
• Fucoidan Induces Cancer Cell Apoptosis by Modulating the Endoplasmic Reticulum Stress Cascades Cite
  Chen S, Zhao Y, Zhang Y, Zhang D. Fucoidan Induces Cancer Cell Apoptosis by Modulating the Endoplasmic Reticulum Stress Cascades. PLoS ONE. Public Library of Science (PLoS); 2014; 9:e108157 10.1371/journal.pone.0108157
• Parity, Lactation, and Breast Cancer Subtypes in African American Women: Results from the AMBER Consortium Cite
  Palmer JR, Viscidi E, Troester MA, Hong C, Schedin P, Bethea TN, et al. Parity, Lactation, and Breast Cancer Subtypes in African American Women: Results from the AMBER Consortium. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2014; 106 10.1093/jnci/dju237
• Genistein inhibits MDA-MB-231 triple-negative breast cancer cell growth by inhibiting NF-κB activity via the Notch-1 pathway Cite
  PAN H, ZHOU W, HE W, LIU X, DING Q, LING L, et al. Genistein inhibits MDA-MB-231 triple-negative breast cancer cell growth by inhibiting NF-κB activity via the Notch-1 pathway. International Journal of Molecular Medicine. Spandidos Publications; 2012; 30:337-343 10.3892/ijmm.2012.990
• Metformin-Induced Killing of Triple-Negative Breast Cancer Cells Is Mediated by Reduction in Fatty Acid Synthase via miRNA-193b Cite
  Wahdan-Alaswad RS, Cochrane DR, Spoelstra NS, Howe EN, Edgerton SM, Anderson SM, et al. Metformin-Induced Killing of Triple-Negative Breast Cancer Cells Is Mediated by Reduction in Fatty Acid Synthase via miRNA-193b. Hormones and Cancer. Springer Science and Business Media LLC; 2014; 5:374-389 10.1007/s12672-014-0188-8
• Discovery of lesser known flavones as inhibitors of NF-κB signaling in MDA-MB-231 breast cancer cells—A SAR study Cite
  Amrutha K, Nanjan P, Shaji SK, Sunilkumar D, Subhalakshmi K, Rajakrishna L, et al. Discovery of lesser known flavones as inhibitors of NF-κB signaling in MDA-MB-231 breast cancer cells—A SAR study. Bioorganic & Medicinal Chemistry Letters. Elsevier BV; 2014; 24:4735-4742 10.1016/j.bmcl.2014.07.093
• Cucurbitacin E Induces Cell Cycle G2/M Phase Arrest and Apoptosis in Triple Negative Breast Cancer Cite
  Kong Y, Chen J, Zhou Z, Xia H, Qiu M, Chen C. Cucurbitacin E Induces Cell Cycle G2/M Phase Arrest and Apoptosis in Triple Negative Breast Cancer. PLoS ONE. Public Library of Science (PLoS); 2014; 9:e103760 10.1371/journal.pone.0103760
• Retroviral-infection increases tumorigenic potential of MDA-MB-231 breast carcinoma cells by expanding an aldehyde dehydrogenase (ALDH1) positive stem-cell like population Cite
  Wegman-Points LJ, Teoh-Fitzgerald ML, Mao G, Zhu Y, Fath MA, Spitz DR, et al. Retroviral-infection increases tumorigenic potential of MDA-MB-231 breast carcinoma cells by expanding an aldehyde dehydrogenase (ALDH1) positive stem-cell like population. Redox Biology. Elsevier BV; 2014; 2:847-854 10.1016/j.redox.2014.06.006
• Perfluorooctanoic acid stimulates breast cancer cells invasion and up-regulates matrix metalloproteinase-2/-9 expression mediated by activating NF-κB Cite
  Zhang W, Wang F, Xu P, Miao C, Zeng X, Cui X, et al. Perfluorooctanoic acid stimulates breast cancer cells invasion and up-regulates matrix metalloproteinase-2/-9 expression mediated by activating NF-κB. Toxicology Letters. Elsevier BV; 2014; 229:118-125 10.1016/j.toxlet.2014.06.004
• Quercetin-3-O-glucuronide inhibits noradrenaline-promoted invasion of MDA-MB-231 human breast cancer cells by blocking β2-adrenergic signaling Cite
  Yamazaki S, Miyoshi N, Kawabata K, Yasuda M, Shimoi K. Quercetin-3-O-glucuronide inhibits noradrenaline-promoted invasion of MDA-MB-231 human breast cancer cells by blocking β2-adrenergic signaling. Archives of Biochemistry and Biophysics. Elsevier BV; 2014; 557:18-27 10.1016/j.abb.2014.05.030
• Associations between Estrogen Receptor–Negative Breast Cancer and Timing of Reproductive Events Differ between African American and European American Women Cite
  Ambrosone CB, Zirpoli GR, Bovbjerg DH, Shankar J, Hong C, McCann SE, et al. Associations between Estrogen Receptor–Negative Breast Cancer and Timing of Reproductive Events Differ between African American and European American Women. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2014; 23:1115-1120 10.1158/1055-9965.epi-14-0110
• Body mass index, diabetes, and triple-negative breast cancer prognosis Cite
  Tait S, Pacheco JM, Gao F, Bumb C, Ellis MJ, Ma CX. Body mass index, diabetes, and triple-negative breast cancer prognosis. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2014; 146:189-197 10.1007/s10549-014-3002-y
• The metastatic potential of triple-negative breast cancer is decreased via caloric restriction-mediated reduction of the miR-17~92 cluster Cite
  Jin L, Lim M, Zhao S, Sano Y, Simone BA, Savage JE, et al. The metastatic potential of triple-negative breast cancer is decreased via caloric restriction-mediated reduction of the miR-17~92 cluster. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2014; 146:41-50 10.1007/s10549-014-2978-7
• Primary relapse site pattern in women with triple-negative breast cancer Cite
  Beca F, Santos R, Vieira D, Zeferino L, Dufloth R, Schmitt F. Primary relapse site pattern in women with triple-negative breast cancer. Pathology - Research and Practice. Elsevier BV; 2014; 210:571-575 10.1016/j.prp.2014.05.011
• Age at first childbirth and oral contraceptive use are associated with risk of androgen receptor-negative breast cancer: the Malmö Diet and Cancer Cohort Cite
  Elebro K, Butt S, Dorkhan M, Jernström H, Borgquist S. Age at first childbirth and oral contraceptive use are associated with risk of androgen receptor-negative breast cancer: the Malmö Diet and Cancer Cohort. Cancer Causes & Control. Springer Science and Business Media LLC; 2014; 25:945-957 10.1007/s10552-014-0394-2
• Oral Contraceptives and Breast Cancer Risk Overall and by Molecular Subtype Among Young Women Cite
  Beaber EF, Malone KE, Tang MC, Barlow WE, Porter PL, Daling JR, et al. Oral Contraceptives and Breast Cancer Risk Overall and by Molecular Subtype Among Young Women. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2014; 23:755-764 10.1158/1055-9965.epi-13-0944
• US Incidence of Breast Cancer Subtypes Defined by Joint Hormone Receptor and HER2 Status Cite
  Howlader N, Altekruse SF, Li CI, Chen VW, Clarke CA, Ries LAG, et al. US Incidence of Breast Cancer Subtypes Defined by Joint Hormone Receptor and HER2 Status. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2014; 106 10.1093/jnci/dju055
• Which threshold for ER positivity? a retrospective study based on 9639 patients Cite
  Yi M, Huo L, Koenig K, Mittendorf E, Meric-Bernstam F, Kuerer H, et al. Which threshold for ER positivity? a retrospective study based on 9639 patients. Annals of Oncology. Elsevier BV; 2014; 25:1004-1011 10.1093/annonc/mdu053
• The mushroom Ganoderma lucidum suppresses breast-to-lung cancer metastasis through the inhibition of pro-invasive genes Cite
  LOGANATHAN J, JIANG J, SMITH A, JEDINAK A, THYAGARAJAN-SAHU A, SANDUSKY GE, et al. The mushroom Ganoderma lucidum suppresses breast-to-lung cancer metastasis through the inhibition of pro-invasive genes. International Journal of Oncology. Spandidos Publications; 2014; 44:2009-2015 10.3892/ijo.2014.2375
• Predictive Factors and Patterns of Recurrence in Patients with Triple Negative Breast Cancer Cite
  Steward L, Conant L, Gao F, Margenthaler JA. Predictive Factors and Patterns of Recurrence in Patients with Triple Negative Breast Cancer. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2014; 21:2165-2171 10.1245/s10434-014-3546-4
• Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis Cite
  Cortazar P, Zhang L, Untch M, Mehta K, Costantino JP, Wolmark N, et al. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. The Lancet. Elsevier BV; 2014; 384:164-172 10.1016/s0140-6736(13)62422-8
• Luteolin enhances paclitaxel-induced apoptosis in human breast cancer MDA-MB-231 cells by blocking STAT3 Cite
  Yang M, Wang C, Chen N, Ho W, Lu F, Tseng T. Luteolin enhances paclitaxel-induced apoptosis in human breast cancer MDA-MB-231 cells by blocking STAT3. Chemico-Biological Interactions. Elsevier BV; 2014; 213:60-68 10.1016/j.cbi.2014.02.002
• Clinical Significance of HER2-Positive and Triple-Negative Status in Small (≤ 1 cm) Node-Negative Breast Cancer Cite
  Gorshein E, Klein P, Boolbol SK, Shao T. Clinical Significance of HER2-Positive and Triple-Negative Status in Small (≤ 1 cm) Node-Negative Breast Cancer. Clinical Breast Cancer. Elsevier BV; 2014; 14:309-314 10.1016/j.clbc.2014.02.007
• Arachidonic acid promotes migration and invasion through a PI3K/Akt-dependent pathway in MDA-MB-231 breast cancer cells Cite
  Villegas-Comonfort S, Castillo-Sanchez R, Serna-Marquez N, Cortes-Reynosa P, Salazar EP. Arachidonic acid promotes migration and invasion through a PI3K/Akt-dependent pathway in MDA-MB-231 breast cancer cells. Prostaglandins, Leukotrienes and Essential Fatty Acids. Elsevier BV; 2014; 90:169-177 10.1016/j.plefa.2014.01.007
• The anti-proliferative effect of metformin in triple-negative MDA-MB-231 breast cancer cells is highly dependent on glucose concentration: Implications for cancer therapy and prevention Cite
  Zordoky BN, Bark D, Soltys CL, Sung MM, Dyck JR. The anti-proliferative effect of metformin in triple-negative MDA-MB-231 breast cancer cells is highly dependent on glucose concentration: Implications for cancer therapy and prevention. Biochimica et Biophysica Acta (BBA) - General Subjects. Elsevier BV; 2014; 1840:1943-1957 10.1016/j.bbagen.2014.01.023
• Delphinidin inhibits cell proliferation and induces apoptosis in MDA-MB-231 human breast cancer cell lines Cite
  Seo EY. Delphinidin inhibits cell proliferation and induces apoptosis in MDA-MB-231 human breast cancer cell lines. Journal of Nutrition and Health. The Korean Nutrition Society; 2013; 46:503 10.4163/jnh.2013.46.6.503
• Time-dependent risk of developing distant metastasis in breast cancer patients according to treatment, age and tumour characteristics Cite
  Colzani E, Johansson ALV, Liljegren A, Foukakis T, Clements M, Adolfsson J, et al. Time-dependent risk of developing distant metastasis in breast cancer patients according to treatment, age and tumour characteristics. British Journal of Cancer. Springer Science and Business Media LLC; 2014; 110:1378-1384 10.1038/bjc.2014.5
• Human Adipose Tissue-Derived Stromal/Stem Cells Promote Migration and Early Metastasis of Triple Negative Breast Cancer Xenografts Cite
  Rowan BG, Gimble JM, Sheng M, Anbalagan M, Jones RK, Frazier TP, et al. Human Adipose Tissue-Derived Stromal/Stem Cells Promote Migration and Early Metastasis of Triple Negative Breast Cancer Xenografts. PLoS ONE. Public Library of Science (PLoS); 2014; 9:e89595 10.1371/journal.pone.0089595
• Pepper Seed Extract Suppresses Invasion and Migration of Human Breast Cancer Cells Cite
  Kim H, Kim M, Kim S, Kim YK. Pepper Seed Extract Suppresses Invasion and Migration of Human Breast Cancer Cells. Nutrition and Cancer. Informa UK Limited; 2013; 66:159-165 10.1080/01635581.2014.853814
• Survival Outcomes in Breast Cancer Patients With Low Estrogen/Progesterone Receptor Expression Cite
  Balduzzi A, Bagnardi V, Rotmensz N, Dellapasqua S, Montagna E, Cardillo A, et al. Survival Outcomes in Breast Cancer Patients With Low Estrogen/Progesterone Receptor Expression. Clinical Breast Cancer. Elsevier BV; 2014; 14:258-264 10.1016/j.clbc.2013.10.019
• Androgen Receptor Expression and Outcomes in Early Breast Cancer: A Systematic Review and Meta-Analysis Cite
  Vera-Badillo FE, Templeton AJ, de Gouveia P, Diaz-Padilla I, Bedard PL, Al-Mubarak M, et al. Androgen Receptor Expression and Outcomes in Early Breast Cancer: A Systematic Review and Meta-Analysis. JNCI Journal of the National Cancer Institute. Oxford University Press (OUP); 2013; 106:djt319-djt319 10.1093/jnci/djt319
• Whole Blueberry Powder Inhibits Metastasis of Triple Negative Breast Cancer in a Xenograft Mouse Model Through Modulation of Inflammatory Cytokines Cite
  Kanaya N, Adams L, Takasaki A, Chen S. Whole Blueberry Powder Inhibits Metastasis of Triple Negative Breast Cancer in a Xenograft Mouse Model Through Modulation of Inflammatory Cytokines. Nutrition and Cancer. Informa UK Limited; 2013; 66:242-248 10.1080/01635581.2014.863366
• Parity and breastfeeding among African-American women: differential effects on breast cancer risk by estrogen receptor status in the Women’s Circle of Health Study Cite
  Ambrosone CB, Zirpoli G, Ruszczyk M, Shankar J, Hong C, McIlwain D, et al. Parity and breastfeeding among African-American women: differential effects on breast cancer risk by estrogen receptor status in the Women’s Circle of Health Study. Cancer Causes & Control. Springer Science and Business Media LLC; 2013; 25:259-265 10.1007/s10552-013-0323-9
• Modeling vitamin D actions in triple negative/basal-like breast cancer Cite
  LaPorta E, Welsh J. Modeling vitamin D actions in triple negative/basal-like breast cancer. The Journal of Steroid Biochemistry and Molecular Biology. Elsevier BV; 2014; 144:65-73 10.1016/j.jsbmb.2013.10.022
• Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin Cite
  Kim TH, Shin YJ, Won AJ, Lee BM, Choi WS, Jung JH, et al. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin. Biochimica et Biophysica Acta (BBA) - General Subjects. Elsevier BV; 2014; 1840:615-625 10.1016/j.bbagen.2013.10.023
• Triple Negative Breast Tumors in African-American and Hispanic/Latina Women Are High in CD44+, Low in CD24+, and Have Loss of PTEN Cite
  Wu Y, Sarkissyan M, Elshimali Y, Vadgama JV. Triple Negative Breast Tumors in African-American and Hispanic/Latina Women Are High in CD44+, Low in CD24+, and Have Loss of PTEN. PLoS ONE. Public Library of Science (PLoS); 2013; 8:e78259 10.1371/journal.pone.0078259
• Metformin reverses multidrug resistance and epithelial–mesenchymal transition (EMT) via activating AMP-activated protein kinase (AMPK) in human breast cancer cells Cite
  Qu C, Zhang W, Zheng G, Zhang Z, Yin J, He Z. Metformin reverses multidrug resistance and epithelial–mesenchymal transition (EMT) via activating AMP-activated protein kinase (AMPK) in human breast cancer cells. Molecular and Cellular Biochemistry. Springer Science and Business Media LLC; 2013; 386:63-71 10.1007/s11010-013-1845-x
• DHA is a more potent inhibitor of breast cancer metastasis to bone and related osteolysis than EPA Cite
  Rahman MM, Veigas JM, Williams PJ, Fernandes G. DHA is a more potent inhibitor of breast cancer metastasis to bone and related osteolysis than EPA. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2013; 141:341-352 10.1007/s10549-013-2703-y
• Dietary patterns and breast cancer risk in the California Teachers Study cohort Cite
  Link LB, Canchola AJ, Bernstein L, Clarke CA, Stram DO, Ursin G, et al. Dietary patterns and breast cancer risk in the California Teachers Study cohort. The American Journal of Clinical Nutrition. Oxford University Press (OUP); 2013; 98:1524-1532 10.3945/ajcn.113.061184
• Estradiol increases ER-negative breast cancer metastasis in an experimental model Cite
  Yang X, Belosay A, Du M, Fan TM, Turner RT, Iwaniec UT, et al. Estradiol increases ER-negative breast cancer metastasis in an experimental model. Clinical & Experimental Metastasis. Springer Science and Business Media LLC; 2013; 30:711-721 10.1007/s10585-012-9559-0
• Inhibition of Type I Insulin-Like Growth Factor Receptor Signaling Attenuates the Development of Breast Cancer Brain Metastasis Cite
  Saldana SM, Lee H, Lowery FJ, Khotskaya YB, Xia W, Zhang C, et al. Inhibition of Type I Insulin-Like Growth Factor Receptor Signaling Attenuates the Development of Breast Cancer Brain Metastasis. PLoS ONE. Public Library of Science (PLoS); 2013; 8:e73406 10.1371/journal.pone.0073406
• Irradiation of Juvenile, but not Adult, Mammary Gland Increases Stem Cell Self-Renewal and Estrogen Receptor Negative Tumors Cite
  Tang J, Fernandez-Garcia I, Vijayakumar S, Martinez-Ruis H, Illa-Bochaca I, Nguyen DH, et al. Irradiation of Juvenile, but not Adult, Mammary Gland Increases Stem Cell Self-Renewal and Estrogen Receptor Negative Tumors. STEM CELLS. Wiley; 2014; 32:649-661 10.1002/stem.1533
• Hormone Receptor-Negative Breast Cancer: Undertreatment of Patients Over 80 Cite
  Weiss A, Noorbaksh A, Tokin C, Chang D, Blair SL. Hormone Receptor-Negative Breast Cancer: Undertreatment of Patients Over 80. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2013; 20:3274-3278 10.1245/s10434-013-3115-2
• Prospective Observational Study of Breast Cancer Treatment Outcomes for UK Women Aged 18–40 Years at Diagnosis: The POSH Study Cite
  Copson E, Eccles B, Maishman T, Gerty S, Stanton L, Cutress RI, et al. Prospective Observational Study of Breast Cancer Treatment Outcomes for UK Women Aged 18–40 Years at Diagnosis: The POSH Study. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2013; 105:978-988 10.1093/jnci/djt134
• High glucose and insulin differentially modulates proliferation in MCF-7 and MDA-MB-231 cells Cite
  Gupta C, Tikoo K. High glucose and insulin differentially modulates proliferation in MCF-7 and MDA-MB-231 cells. Journal of Molecular Endocrinology. Bioscientifica; 2013; 51:119-129 10.1530/jme-13-0062
• Naringin inhibits growth potential of human triple-negative breast cancer cells by targeting β-catenin signaling pathway Cite
  Li H, Yang B, Huang J, Xiang T, Yin X, Wan J, et al. Naringin inhibits growth potential of human triple-negative breast cancer cells by targeting β-catenin signaling pathway. Toxicology Letters. Elsevier BV; 2013; 220:219-228 10.1016/j.toxlet.2013.05.006
• Caloric restriction augments radiation efficacy in breast cancer Cite
  Saleh A, Simone B, Palazzo J, Savage JE, Sano Y, Dan T, et al. Caloric restriction augments radiation efficacy in breast cancer. Cell Cycle. Informa UK Limited; 2013; 12:1955-1963 10.4161/cc.25016
• Quercetin and epigallocatechin gallate inhibit glucose uptake and metabolism by breast cancer cells by an estrogen receptor-independent mechanism Cite
  Moreira L, Araújo I, Costa T, Correia-Branco A, Faria A, Martel F, et al. Quercetin and epigallocatechin gallate inhibit glucose uptake and metabolism by breast cancer cells by an estrogen receptor-independent mechanism. Experimental Cell Research. Elsevier BV; 2013; 319:1784-1795 10.1016/j.yexcr.2013.05.001
• Evaluation of the anti-angiogenic action of melatonin in breast cancer Cite
  Jardim BV, Ferreira LC, Borin TF, Moschetta MG, Gelaleti GB, Lopes JR, et al. Evaluation of the anti-angiogenic action of melatonin in breast cancer. BMC Proceedings. Springer Science and Business Media LLC; 2013; 7 10.1186/1753-6561-7-s2-p11
• Intake of specific fruits and vegetables in relation to risk of estrogen receptor-negative breast cancer among postmenopausal women Cite
  Fung TT, Chiuve SE, Willett WC, Hankinson SE, Hu FB, Holmes MD. Intake of specific fruits and vegetables in relation to risk of estrogen receptor-negative breast cancer among postmenopausal women. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2013; 138:925-930 10.1007/s10549-013-2484-3
• High Coffee Intake, but Not Caffeine, is Associated with Reduced Estrogen Receptor Negative and Postmenopausal Breast Cancer Risk with No Effect Modification by CYP1A2 Genotype Cite
  Lowcock EC, Cotterchio M, Anderson LN, Boucher BA, El-Sohemy A. High Coffee Intake, but Not Caffeine, is Associated with Reduced Estrogen Receptor Negative and Postmenopausal Breast Cancer Risk with No Effect Modification by CYP1A2 Genotype. Nutrition and Cancer. Informa UK Limited; 2013; 65:398-409 10.1080/01635581.2013.768348
• Pterostilbene, a bioactive component of blueberries, suppresses the generation of breast cancer stem cells within tumor microenvironment and metastasis via modulating NF-κB/microRNA 448 circuit Cite
  Mak K, Wu ATH, Lee W, Chang T, Chiou J, Wang L, et al. Pterostilbene, a bioactive component of blueberries, suppresses the generation of breast cancer stem cells within tumor microenvironment and metastasis via modulating NF-κB/microRNA 448 circuit. Molecular Nutrition & Food Research. Wiley; 2013; 57:1123-1134 10.1002/mnfr.201200549
• Triple-negative Breast Carcinoma in African American and Caucasian Women Cite
  Sullivan HC, Oprea-Ilies G, Adams AL, Page AJ, Kim S, Wang J, et al. Triple-negative Breast Carcinoma in African American and Caucasian Women. Applied Immunohistochemistry & Molecular Morphology. Ovid Technologies (Wolters Kluwer Health); 2014; 22:17-23 10.1097/pai.0b013e318281148e
• Invadopodia-associated proteins blockade as a novel mechanism for 6-shogaol and pterostilbene to reduce breast cancer cell motility and invasion Cite
  Hong B, Wu C, Yeh C, Yen G. Invadopodia-associated proteins blockade as a novel mechanism for 6-shogaol and pterostilbene to reduce breast cancer cell motility and invasion. Molecular Nutrition & Food Research. Wiley; 2013; 57:886-895 10.1002/mnfr.201200715
• Resveratrol activates the histone H2B ubiquitin ligase, RNF20, in MDA-MB-231 breast cancer cells Cite
  Lin C, Hsiao W, Wright DE, Hsu C, Lo Y, Wang Hsu G, et al. Resveratrol activates the histone H2B ubiquitin ligase, RNF20, in MDA-MB-231 breast cancer cells. Journal of Functional Foods. Elsevier BV; 2013; 5:790-800 10.1016/j.jff.2013.01.025
• Delta-6-desaturase activity and arachidonic acid synthesis are increased in human breast cancer tissue Cite
  Pender-Cudlip MC, Krag KJ, Martini D, Yu J, Guidi A, Skinner SS, et al. Delta-6-desaturase activity and arachidonic acid synthesis are increased in human breast cancer tissue. Cancer Science. Wiley; 2013; 104:760-764 10.1111/cas.12129
• Critical role for reactive oxygen species in apoptosis induction and cell migration inhibition by diallyl trisulfide, a cancer chemopreventive component of garlic Cite
  Chandra-Kuntal K, Lee J, Singh SV. Critical role for reactive oxygen species in apoptosis induction and cell migration inhibition by diallyl trisulfide, a cancer chemopreventive component of garlic. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2013; 138:69-79 10.1007/s10549-013-2440-2
• Tetrathiomolybdate-associated copper depletion decreases circulating endothelial progenitor cells in women with breast cancer at high risk of relapse Cite
  Jain S, Cohen J, Ward M, Kornhauser N, Chuang E, Cigler T, et al. Tetrathiomolybdate-associated copper depletion decreases circulating endothelial progenitor cells in women with breast cancer at high risk of relapse. Annals of Oncology. Elsevier BV; 2013; 24:1491-1498 10.1093/annonc/mds654
• Sulforaphane inhibits growth of phenotypically different breast cancer cells Cite
  Pawlik A, Wiczk A, Kaczyńska A, Antosiewicz J, Herman-Antosiewicz A. Sulforaphane inhibits growth of phenotypically different breast cancer cells. European Journal of Nutrition. Springer Science and Business Media LLC; 2013; 52:1949-1958 10.1007/s00394-013-0499-5
• Phenotypic Switch in Blood: Effects of Pro-Inflammatory Cytokines on Breast Cancer Cell Aggregation and Adhesion Cite
  Geng Y, Chandrasekaran S, Hsu J, Gidwani M, Hughes AD, King MR. Phenotypic Switch in Blood: Effects of Pro-Inflammatory Cytokines on Breast Cancer Cell Aggregation and Adhesion. PLoS ONE. Public Library of Science (PLoS); 2013; 8:e54959 10.1371/journal.pone.0054959
• Distant metastasis in triple-negative breast cancer Cite
  TSENG LM, HSU NC, CHEN SC, LU YS, LIN CH, CHANG DY, et al. Distant metastasis in triple-negative breast cancer. Neoplasma. AEPress, s.r.o.; 2013; 60:290-294 10.4149/neo_2013_038
• Fruit and Vegetable Intake and Risk of Breast Cancer by Hormone Receptor Status Cite
  Jung S, Spiegelman D, Baglietto L, Bernstein L, Boggs DA, van den Brandt PA, et al. Fruit and Vegetable Intake and Risk of Breast Cancer by Hormone Receptor Status. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2013; 105:219-236 10.1093/jnci/djs635
• BRCA1 loss activates cathepsin L–mediated degradation of 53BP1 in breast cancer cells Cite
  Grotsky DA, Gonzalez-Suarez I, Novell A, Neumann MA, Yaddanapudi SC, Croke M, et al. BRCA1 loss activates cathepsin L–mediated degradation of 53BP1 in breast cancer cells. Journal of Cell Biology. Rockefeller University Press; 2013; 200:187-202 10.1083/jcb.201204053
• Breast cancer subtype approximations and loco-regional recurrence after immediate breast reconstruction Cite
  Kneubil M, Brollo J, Botteri E, Curigliano G, Rotmensz N, Goldhirsch A, et al. Breast cancer subtype approximations and loco-regional recurrence after immediate breast reconstruction. European Journal of Surgical Oncology (EJSO). Elsevier BV; 2013; 39:260-265 10.1016/j.ejso.2012.12.004
• The depletion of Interleukin-8 causes cell cycle arrest and increases the efficacy of docetaxel in breast cancer cells Cite
  Shao N, Chen L, Ye R, Lin Y, Wang S. The depletion of Interleukin-8 causes cell cycle arrest and increases the efficacy of docetaxel in breast cancer cells. Biochemical and Biophysical Research Communications. Elsevier BV; 2013; 431:535-541 10.1016/j.bbrc.2013.01.022
• Analysis of pattern, time and risk factors influencing recurrence in triple-negative breast cancer patients Cite
  Pogoda K, Niwińska A, Murawska M, Pieńkowski T. Analysis of pattern, time and risk factors influencing recurrence in triple-negative breast cancer patients. Medical Oncology. Springer Science and Business Media LLC; 2013; 30 10.1007/s12032-012-0388-4
• Dietary grape polyphenol resveratrol increases mammary tumor growth and metastasis in immunocompromised mice Cite
  Castillo-Pichardo L, Cubano LA, Dharmawardhane S. Dietary grape polyphenol resveratrol increases mammary tumor growth and metastasis in immunocompromised mice. BMC Complementary and Alternative Medicine. Springer Science and Business Media LLC; 2013; 13 10.1186/1472-6882-13-6
• Postmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up Cite
  Zhang X, Tworoger SS, Eliassen AH, Hankinson SE. Postmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2013; 137:883-892 10.1007/s10549-012-2391-z
• Chrysin: A Histone Deacetylase 8 Inhibitor with Anticancer Activity and a Suitable Candidate for the Standardization of Chinese Propolis Cite
  Sun L, Chen A, Hung H, Chien Y, Huang J, Huang C, et al. Chrysin: A Histone Deacetylase 8 Inhibitor with Anticancer Activity and a Suitable Candidate for the Standardization of Chinese Propolis. Journal of Agricultural and Food Chemistry. American Chemical Society (ACS); 2012; 60:11748-11758 10.1021/jf303261r
• Height, age at menarche and risk of hormone receptor-positive and -negative breast cancer: A cohort study Cite
  Ritte R, Lukanova A, Tjønneland A, Olsen A, Overvad K, Mesrine S, et al. Height, age at menarche and risk of hormone receptor-positive and -negative breast cancer: A cohort study. International Journal of Cancer. Wiley; 2012; 132:2619-2629 10.1002/ijc.27913
• Heterogeneity of Triple-Negative Breast Cancer: Histologic Subtyping to Inform the Outcome Cite
  Montagna E, Maisonneuve P, Rotmensz N, Cancello G, Iorfida M, Balduzzi A, et al. Heterogeneity of Triple-Negative Breast Cancer: Histologic Subtyping to Inform the Outcome. Clinical Breast Cancer. Elsevier BV; 2013; 13:31-39 10.1016/j.clbc.2012.09.002
• Modulation of CYP19 expression by cabbage juices and their active components: indole-3-carbinol and 3,3′-diindolylmethene in human breast epithelial cell lines Cite
  Licznerska BE, Szaefer H, Murias M, Bartoszek A, Baer-Dubowska W. Modulation of CYP19 expression by cabbage juices and their active components: indole-3-carbinol and 3,3′-diindolylmethene in human breast epithelial cell lines. European Journal of Nutrition. Springer Science and Business Media LLC; 2012; 52:1483-1492 10.1007/s00394-012-0455-9
• Pomegranate juice and specific components inhibit cell and molecular processes critical for metastasis of breast cancer Cite
  Rocha A, Wang L, Penichet M, Martins-Green M. Pomegranate juice and specific components inhibit cell and molecular processes critical for metastasis of breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2012; 136:647-658 10.1007/s10549-012-2264-5
• Docosahexanoic Acid Improves Chemotherapy Efficacy by Inducing CD95 Translocation to Lipid Rafts in ER− Breast Cancer Cells Cite
  Ewaschuk JB, Newell M, Field CJ. Docosahexanoic Acid Improves Chemotherapy Efficacy by Inducing CD95 Translocation to Lipid Rafts in ER− Breast Cancer Cells. Lipids. Wiley; 2012; 47:1019-1030 10.1007/s11745-012-3717-7
• Impact of Body Mass Index on Survival Outcome Among Women With Early Stage Triple-Negative Breast Cancer Cite
  Dawood S, Lei X, Litton JK, Buchholz TA, Hortobagyi GN, Gonzalez-Angulo AM. Impact of Body Mass Index on Survival Outcome Among Women With Early Stage Triple-Negative Breast Cancer. Clinical Breast Cancer. Elsevier BV; 2012; 12:364-372 10.1016/j.clbc.2012.07.013
• Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single-Institution analysis Cite
  Dieci M, Barbieri E, Piacentini F, Ficarra G, Bettelli S, Dominici M, et al. Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single-Institution analysis. Annals of Oncology. Elsevier BV; 2013; 24:101-108 10.1093/annonc/mds248
• Cytotoxicity of pomegranate polyphenolics in breast cancer cells in vitro and vivo: potential role of miRNA-27a and miRNA-155 in cell survival and inflammation Cite
  Banerjee N, Talcott S, Safe S, Mertens-Talcott SU. Cytotoxicity of pomegranate polyphenolics in breast cancer cells in vitro and vivo: potential role of miRNA-27a and miRNA-155 in cell survival and inflammation. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2012; 136:21-34 10.1007/s10549-012-2224-0
• In Vitro and in Vivo Antimammary Tumor Activities and Mechanisms of the Apple Total Triterpenoids Cite
  He X, Wang Y, Hu H, Zhang Z. In Vitro and in Vivo Antimammary Tumor Activities and Mechanisms of the Apple Total Triterpenoids. Journal of Agricultural and Food Chemistry. American Chemical Society (ACS); 2012; 60:9430-9436 10.1021/jf3026925
• Luteolin exerts anti-tumor activity through the suppression of epidermal growth factor receptor-mediated pathway in MDA-MB-231 ER-negative breast cancer cells Cite
  Lee E, Oh S, Sung M. Luteolin exerts anti-tumor activity through the suppression of epidermal growth factor receptor-mediated pathway in MDA-MB-231 ER-negative breast cancer cells. Food and Chemical Toxicology. Elsevier BV; 2012; 50:4136-4143 10.1016/j.fct.2012.08.025
• High levels of arachidonic acid and peroxisome proliferator-activated receptor-alpha in breast cancer tissues are associated with promoting cancer cell proliferation Cite
  Chang N, Wu C, Chen D, Yeh C, Lin C. High levels of arachidonic acid and peroxisome proliferator-activated receptor-alpha in breast cancer tissues are associated with promoting cancer cell proliferation. The Journal of Nutritional Biochemistry. Elsevier BV; 2013; 24:274-281 10.1016/j.jnutbio.2012.06.005
• Factors Associated With Local-Regional Recurrence After a Negative Sentinel Node Dissection Cite
  Hunt KK, Ballman KV, McCall LM, Boughey JC, Mittendorf EA, Cox CE, et al. Factors Associated With Local-Regional Recurrence After a Negative Sentinel Node Dissection. Annals of Surgery. Ovid Technologies (Wolters Kluwer Health); 2012; 256:428-436 10.1097/sla.0b013e3182654494
• Obesity or Overweight Is Associated with Worse Pathological Response to Neoadjuvant Chemotherapy among Chinese Women with Breast Cancer Cite
  Chen S, Chen C, Zhou Y, Zhou R, Yu K, Shao Z. Obesity or Overweight Is Associated with Worse Pathological Response to Neoadjuvant Chemotherapy among Chinese Women with Breast Cancer. PLoS ONE. Public Library of Science (PLoS); 2012; 7:e41380 10.1371/journal.pone.0041380
• Alcohol Consumption and Breast Cancer Risk Among Postmenopausal Women Following the Cessation of Hormone Therapy Use: The California Teachers Study Cite
  Horn-Ross PL, Canchola AJ, Bernstein L, Clarke CA, Lacey JV, Neuhausen SL, et al. Alcohol Consumption and Breast Cancer Risk Among Postmenopausal Women Following the Cessation of Hormone Therapy Use: The California Teachers Study. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2012; 21:2006-2013 10.1158/1055-9965.epi-12-0418
• The role of cardiac glycosides in influencing breast cancer cell proliferation Cite
  Quinlan K, Owens M, Hill A, Hopkins A. The role of cardiac glycosides in influencing breast cancer cell proliferation. BMC Proceedings. Springer Science and Business Media LLC; 2012; 6 10.1186/1753-6561-6-s4-p1
• Age-Specific Incidence of Breast Cancer Subtypes: Understanding the Black–White Crossover Cite
  Clarke CA, Keegan THM, Yang J, Press DJ, Kurian AW, Patel AH, et al. Age-Specific Incidence of Breast Cancer Subtypes: Understanding the Black–White Crossover. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2012; 104:1094-1101 10.1093/jnci/djs264
• Dietary glycemic index and glycemic load and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) Cite
  Romieu I, Ferrari P, Rinaldi S, Slimani N, Jenab M, Olsen A, et al. Dietary glycemic index and glycemic load and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). The American Journal of Clinical Nutrition. Oxford University Press (OUP); 2012; 96:345-355 10.3945/ajcn.111.026724
• Association of core needle biopsies with increase in metastatic dissemination of breast cancer. Cite
  Giacomantonio CA, Dean CA, Mathenge EG, Black AA, Schulte W, Pink DB, et al. Association of core needle biopsies with increase in metastatic dissemination of breast cancer.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2012; 30:e21090-e21090 10.1200/jco.2012.30.15_suppl.e21090
• Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study Cite
  Ritte R, Lukanova A, Berrino F, Dossus L, Tjønneland A, Olsen A, et al. Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study. Breast Cancer Research. Springer Science and Business Media LLC; 2012; 14 10.1186/bcr3186
• Are there high-risk subgroups for isolated locoregional failure in patients who had T1/2 breast cancer with one to three positive lymph nodes and received mastectomy without radiotherapy? Cite
  Hamamoto Y, Ohsumi S, Aogi K, Shinohara S, Nakajima N, Kataoka M, et al. Are there high-risk subgroups for isolated locoregional failure in patients who had T1/2 breast cancer with one to three positive lymph nodes and received mastectomy without radiotherapy?. Breast Cancer. Springer Science and Business Media LLC; 2012; 21:177-182 10.1007/s12282-012-0369-7
• Body size and breast cancer prognosis in relation to hormone receptor and menopausal status: a meta-analysis Cite
  Niraula S, Ocana A, Ennis M, Goodwin PJ. Body size and breast cancer prognosis in relation to hormone receptor and menopausal status: a meta-analysis. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2012; 134:769-781 10.1007/s10549-012-2073-x
• Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network Cite
  Lin NU, Vanderplas A, Hughes ME, Theriault RL, Edge SB, Wong Y, et al. Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network. Cancer. Wiley; 2012; 118:5463-5472 10.1002/cncr.27581
• Survival and clinicopathological characteristics of breast cancer patient according to different tumour subtypes as determined by hormone receptor and Her2 immunohistochemistry. A single institution survey spanning 1998 to 2010 Cite
  García Fernández A, Giménez N, Fraile M, González S, Chabrera C, Torras M, et al. Survival and clinicopathological characteristics of breast cancer patient according to different tumour subtypes as determined by hormone receptor and Her2 immunohistochemistry. A single institution survey spanning 1998 to 2010. The Breast. Elsevier BV; 2012; 21:366-373 10.1016/j.breast.2012.03.004
• Benzyl Isothiocyanate Causes FoxO1-Mediated Autophagic Death in Human Breast Cancer Cells Cite
  Xiao D, Bommareddy A, Kim S, Sehrawat A, Hahm E, Singh SV. Benzyl Isothiocyanate Causes FoxO1-Mediated Autophagic Death in Human Breast Cancer Cells. PLoS ONE. Public Library of Science (PLoS); 2012; 7:e32597 10.1371/journal.pone.0032597
• Ellagic acid, a phenolic compound, exerts anti-angiogenesis effects via VEGFR-2 signaling pathway in breast cancer Cite
  Wang N, Wang Z, Mo S, Loo TY, Wang D, Luo H, et al. Ellagic acid, a phenolic compound, exerts anti-angiogenesis effects via VEGFR-2 signaling pathway in breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2012; 134:943-955 10.1007/s10549-012-1977-9
• ERα signaling imparts chemotherapeutic selectivity to selenium nanoparticles in breast cancer Cite
  Vekariya KK, Kaur J, Tikoo K. ERα signaling imparts chemotherapeutic selectivity to selenium nanoparticles in breast cancer. Nanomedicine: Nanotechnology, Biology and Medicine. Elsevier BV; 2012; 8:1125-1132 10.1016/j.nano.2011.12.003
• Radiation Effects on Development of HER2-Positive Breast Carcinomas Cite
  Castiglioni F, Terenziani M, Carcangiu ML, Miliano R, Aiello P, Bertola L, et al. Radiation Effects on Development of HER2-Positive Breast Carcinomas. Clinical Cancer Research. American Association for Cancer Research (AACR); 2007; 13:46-51 10.1158/1078-0432.ccr-06-1490
• Analysis of Clinical Features and Outcome of 356 Triple-Negative Breast Cancer Patients in China Cite
  Zhang L, Hao C, Dong G, Tong Z. Analysis of Clinical Features and Outcome of 356 Triple-Negative Breast Cancer Patients in China. Breast Care. S. Karger AG; 2012; 7:13-17 10.1159/000336539
• Effect of anaesthetic technique on oestrogen receptor-negative breast cancer cell function in vitro † Cite
  Deegan C, Murray D, Doran P, Ecimovic P, Moriarty D, Buggy D. Effect of anaesthetic technique on oestrogen receptor-negative breast cancer cell function in vitro †. British Journal of Anaesthesia. Elsevier BV; 2009; 103:685-690 10.1093/bja/aep261
• Race and Hormone Receptor–Positive Breast Cancer Outcomes in a Randomized Chemotherapy Trial Cite
  Sparano JA, Wang M, Zhao F, Stearns V, Martino S, Ligibel JA, et al. Race and Hormone Receptor–Positive Breast Cancer Outcomes in a Randomized Chemotherapy Trial. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2012; 104:406-414 10.1093/jnci/djr543
• 4-Shogaol, an Active Constituent of Dietary Ginger, Inhibits Metastasis of MDA-MB-231 Human Breast Adenocarcinoma Cells by Decreasing the Repression of NF-κB/Snail on RKIP Cite
  Hsu Y, Chen C, Lin I, Tsai E, Kuo P, Hou M. 4-Shogaol, an Active Constituent of Dietary Ginger, Inhibits Metastasis of MDA-MB-231 Human Breast Adenocarcinoma Cells by Decreasing the Repression of NF-κB/Snail on RKIP. Journal of Agricultural and Food Chemistry. American Chemical Society (ACS); 2011; 60:852-861 10.1021/jf2052515
• Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro Cite
  Alimova IN, Liu B, Fan Z, Edgerton SM, Dillon T, Lind SE, et al. Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro. Cell Cycle. Informa UK Limited; 2009; 8:909-915 10.4161/cc.8.6.7933
• Dietary Intakes of Total and Specific Lignans Are Associated with Clinical Breast Tumor Characteristics Cite
  McCann SE, Hootman KC, Weaver AM, Thompson LU, Morrison C, Hwang H, et al. Dietary Intakes of Total and Specific Lignans Are Associated with Clinical Breast Tumor Characteristics. The Journal of Nutrition. Oxford University Press (OUP); 2011; 142:91-98 10.3945/jn.111.147264
• Endocrine therapy in obese patients with primary breast cancer: another piece of evidence in an unfinished puzzle Cite
  Wolters R, Schwentner L, Regierer A, Wischnewsky M, Kreienberg R, Wöckel A. Endocrine therapy in obese patients with primary breast cancer: another piece of evidence in an unfinished puzzle. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2011; 131:925-931 10.1007/s10549-011-1874-7
• Fucoidan Extract Induces Apoptosis in MCF-7 Cells via a Mechanism Involving the ROS-Dependent JNK Activation and Mitochondria-Mediated Pathways Cite
  Zhang Z, Teruya K, Eto H, Shirahata S. Fucoidan Extract Induces Apoptosis in MCF-7 Cells via a Mechanism Involving the ROS-Dependent JNK Activation and Mitochondria-Mediated Pathways. PLoS ONE. Public Library of Science (PLoS); 2011; 6:e27441 10.1371/journal.pone.0027441
• Luteolin induces apoptotic cell death through AIF nuclear translocation mediated by activation of ERK and p38 in human breast cancer cell lines Cite
  Kim MJ, Woo JS, Kwon CH, Kim JH, Kim YK, Kim KH. Luteolin induces apoptotic cell death through AIF nuclear translocation mediated by activation of ERK and p38 in human breast cancer cell lines. Cell Biology International. Wiley; 2012; 36:339-344 10.1042/cbi20110394
• Phthalates induce proliferation and invasiveness of estrogen receptor‐negative breast cancer through the AhR/HDAC6/c‐Myc signaling pathway Cite
  Hsieh T, Tsai C, Hsu C, Kuo P, Lee J, Chai C, et al. Phthalates induce proliferation and invasiveness of estrogen receptor‐negative breast cancer through the AhR/HDAC6/c‐Myc signaling pathway. The FASEB Journal. Wiley; 2011; 26:778-787 10.1096/fj.11-191742
• Exposure to cadmium chloride influences astrocyte-elevated gene-1 (AEG-1) expression in MDA-MB231 human breast cancer cells Cite
  Luparello C, Longo A, Vetrano M. Exposure to cadmium chloride influences astrocyte-elevated gene-1 (AEG-1) expression in MDA-MB231 human breast cancer cells. Biochimie. Elsevier BV; 2012; 94:207-213 10.1016/j.biochi.2011.10.009
• Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment Cite
  Pasquier E, Ciccolini J, Carre M, Giacometti S, Fanciullino R, Pouchy C, et al. Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment. Oncotarget. Impact Journals, LLC; 2011; 2:797-809 10.18632/oncotarget.343
• Mammographic density and hormone receptor expression in breast cancer: The Multiethnic Cohort Study Cite
  Conroy SM, Pagano I, Kolonel LN, Maskarinec G. Mammographic density and hormone receptor expression in breast cancer: The Multiethnic Cohort Study. Cancer Epidemiology. Elsevier BV; 2011; 35:448-452 10.1016/j.canep.2010.11.011
• Triple-Negative Breast Cancer Is Not a Contraindication for Breast Conservation Cite
  Adkins FC, Gonzalez-Angulo AM, Lei X, Hernandez-Aya LF, Mittendorf EA, Litton JK, et al. Triple-Negative Breast Cancer Is Not a Contraindication for Breast Conservation. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2011; 18:3164-3173 10.1245/s10434-011-1920-z
• Clinically Used Breast Cancer Markers Such As Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Are Unstable Throughout Tumor Progression Cite
  Lindström LS, Karlsson E, Wilking UM, Johansson U, Hartman J, Lidbrink EK, et al. Clinically Used Breast Cancer Markers Such As Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Are Unstable Throughout Tumor Progression. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2012; 30:2601-2608 10.1200/jco.2011.37.2482
• Breast cancer in very young women Cite
  Liukkonen S, Leidenius M, Saarto T, Sjöström-Mattson J. Breast cancer in very young women. European Journal of Surgical Oncology (EJSO). Elsevier BV; 2011; 37:1030-1037 10.1016/j.ejso.2011.08.133
• Dietary flavonoid fisetin targets caspase-3-deficient human breast cancer MCF-7 cells by induction of caspase-7-associated apoptosis and inhibition of autophagy Cite
  Chiu S. Dietary flavonoid fisetin targets caspase-3-deficient human breast cancer MCF-7 cells by induction of caspase-7-associated apoptosis and inhibition of autophagy. International Journal of Oncology. Spandidos Publications; 2011; 10.3892/ijo.2011.1203
• Induction of apoptotic cell death by ursolic acid through mitochondrial death pathway and extrinsic death receptor pathway in MDA-MB-231 cells Cite
  Kim KH, Seo HS, Choi HS, Choi I, Shin YC, Ko S. Induction of apoptotic cell death by ursolic acid through mitochondrial death pathway and extrinsic death receptor pathway in MDA-MB-231 cells. Archives of Pharmacal Research. Springer Science and Business Media LLC; 2011; 34:1363-1372 10.1007/s12272-011-0817-5
• Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study Cite
  Sihto H, Lundin J, Lundin M, Lehtimäki T, Ristimäki A, Holli K, et al. Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study. Breast Cancer Research. Springer Science and Business Media LLC; 2011; 13 10.1186/bcr2944
• Age, Breast Cancer Subtype Approximation, and Local Recurrence After Breast-Conserving Therapy Cite
  Arvold ND, Taghian AG, Niemierko A, Abi Raad RF, Sreedhara M, Nguyen PL, et al. Age, Breast Cancer Subtype Approximation, and Local Recurrence After Breast-Conserving Therapy. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2011; 29:3885-3891 10.1200/jco.2011.36.1105
• Serum Enterolactone and Prognosis of Postmenopausal Breast Cancer Cite
  Buck K, Vrieling A, Zaineddin AK, Becker S, Hüsing A, Kaaks R, et al. Serum Enterolactone and Prognosis of Postmenopausal Breast Cancer. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2011; 29:3730-3738 10.1200/jco.2011.34.6478
• Low-Carbohydrate Diets, Dietary Approaches to Stop Hypertension-Style Diets, and the Risk of Postmenopausal Breast Cancer Cite
  Fung TT, Hu FB, Hankinson SE, Willett WC, Holmes MD. Low-Carbohydrate Diets, Dietary Approaches to Stop Hypertension-Style Diets, and the Risk of Postmenopausal Breast Cancer. American Journal of Epidemiology. Oxford University Press (OUP); 2011; 174:652-660 10.1093/aje/kwr148
• Comparison of locoregional recurrence in triple-negative and HER2-positive breast cancer subtype after breast-conserving therapy and modern systemic therapy. Cite
  Takita C, Reis IM, Miao F, LaFave KE, Gunaseelan V, Hurley J, et al. Comparison of locoregional recurrence in triple-negative and HER2-positive breast cancer subtype after breast-conserving therapy and modern systemic therapy.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2011; 29:112-112 10.1200/jco.2011.29.27_suppl.112
• Direct effect of morphine on breast cancer cell function in vitro : role of the NET1 gene Cite
  Ecimovic P, Murray D, Doran P, McDonald J, Lambert D, Buggy D. Direct effect of morphine on breast cancer cell function in vitro : role of the NET1 gene. British Journal of Anaesthesia. Elsevier BV; 2011; 107:916-923 10.1093/bja/aer259
• Coffee intake and breast cancer risk in the NIH-AARP diet and health study cohort Cite
  Gierach GL, Freedman ND, Andaya A, Hollenbeck AR, Park Y, Schatzkin A, et al. Coffee intake and breast cancer risk in the NIH-AARP diet and health study cohort. International Journal of Cancer. Wiley; 2011; 131:452-460 10.1002/ijc.26372
• Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer Cite
  Bayraktar S, Hernadez-Aya LF, Lei X, Meric-Bernstam F, Litton JK, Hsu L, et al. Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer. Cancer. Wiley; 2011; 118:1202-1211 10.1002/cncr.26439
• Molecular Class as a Predictor of Locoregional and Distant Recurrence in the Neoadjuvant Setting for Breast Cancer Cite
  Vargo JA, Beriwal S, Ahrendt GM, Soran A, Johnson RR, McGuire K, et al. Molecular Class as a Predictor of Locoregional and Distant Recurrence in the Neoadjuvant Setting for Breast Cancer. Oncology. S. Karger AG; 2011; 80:341-349 10.1159/000330203
• Mammographic Breast Density and Subsequent Risk of Breast Cancer in Postmenopausal Women According to Tumor Characteristics Cite
  Yaghjyan L, Colditz GA, Collins LC, Schnitt SJ, Rosner B, Vachon C, et al. Mammographic Breast Density and Subsequent Risk of Breast Cancer in Postmenopausal Women According to Tumor Characteristics. JNCI Journal of the National Cancer Institute. Oxford University Press (OUP); 2011; 103:1179-1189 10.1093/jnci/djr225
• Artichoke polyphenols induce apoptosis and decrease the invasive potential of the human breast cancer cell line MDA-MB231 Cite
  Mileo AM, Di Venere D, Linsalata V, Fraioli R, Miccadei S. Artichoke polyphenols induce apoptosis and decrease the invasive potential of the human breast cancer cell line MDA-MB231. Journal of Cellular Physiology. Wiley; 2012; 227:3301-3309 10.1002/jcp.24029
• Does progesterone receptor status matter in endocrine-responsive breast cancer? Cite
  Coll JM, Healy N, Coyne J, Malone C, McLaughlin R, Keane MM, et al. Does progesterone receptor status matter in endocrine-responsive breast cancer?. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2011; 29:e11085-e11085 10.1200/jco.2011.29.15_suppl.e11085
• Biologic markers determine both the risk and the timing of recurrence in breast cancer Cite
  Esserman LJ, Moore DH, Tsing PJ, Chu PW, Yau C, Ozanne E, et al. Biologic markers determine both the risk and the timing of recurrence in breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2011; 129:607-616 10.1007/s10549-011-1564-5
• Nodal Status and Clinical Outcomes in a Large Cohort of Patients With Triple-Negative Breast Cancer Cite
  Hernandez-Aya LF, Chavez-MacGregor M, Lei X, Meric-Bernstam F, Buchholz TA, Hsu L, et al. Nodal Status and Clinical Outcomes in a Large Cohort of Patients With Triple-Negative Breast Cancer. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2011; 29:2628-2634 10.1200/jco.2010.32.1877
• Caffeic acid phenethyl ester (CAPE), derived from a honeybee product propolis, exhibits a diversity of anti-tumor effects in pre-clinical models of human breast cancer Cite
  Wu J, Omene C, Karkoszka J, Bosland M, Eckard J, Klein CB, et al. Caffeic acid phenethyl ester (CAPE), derived from a honeybee product propolis, exhibits a diversity of anti-tumor effects in pre-clinical models of human breast cancer. Cancer Letters. Elsevier BV; 2011; 308:43-53 10.1016/j.canlet.2011.04.012
• Coffee consumption modifies risk of estrogen-receptor negative breast cancer Cite
  Li J, Seibold P, Chang-Claude J, Flesch-Janys D, Liu J, Czene K, et al. Coffee consumption modifies risk of estrogen-receptor negative breast cancer. Breast Cancer Research. Springer Science and Business Media LLC; 2011; 13 10.1186/bcr2879
• Effect of dietary fiber intake on breast cancer risk according to estrogen and progesterone receptor status Cite
  Zhang C, Ho SC, Cheng S, Chen Y, Fu J, Lin F. Effect of dietary fiber intake on breast cancer risk according to estrogen and progesterone receptor status. European Journal of Clinical Nutrition. Springer Science and Business Media LLC; 2011; 65:929-936 10.1038/ejcn.2011.57
• Fructose as a carbon source induces an aggressive phenotype in MDA-MB-468 breast tumor cells Cite
  Monzavi-Karbassi . Fructose as a carbon source induces an aggressive phenotype in MDA-MB-468 breast tumor cells. International Journal of Oncology. Spandidos Publications; 2010; 37 10.3892/ijo_00000710
• Serum enterolactone and postmenopausal breast cancer risk by estrogen, progesterone and herceptin 2 receptor status Cite
  Zaineddin AK, Vrieling A, Buck K, Becker S, Linseisen J, Flesch-Janys D, et al. Serum enterolactone and postmenopausal breast cancer risk by estrogen, progesterone and herceptin 2 receptor status. International Journal of Cancer. Wiley; 2011; 130:1401-1410 10.1002/ijc.26157
• Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation Cite
  Panoff JE, Hurley J, Takita C, Reis IM, Zhao W, Sujoy V, et al. Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2011; 128:899-906 10.1007/s10549-011-1495-1
• Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes Cite
  Cancello G, Maisonneuve P, Rotmensz N, Viale G, Mastropasqua MG, Pruneri G, et al. Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2011; 127:713-720 10.1007/s10549-011-1465-7
• Abstract 1812: Effects of vitamin D on obesity-induced increase in ER-positive and ER-negative mammary cancer in mice Cite
  Yu W, Kim D, Sumis A, Hilakivi-clarke L. Abstract 1812: Effects of vitamin D on obesity-induced increase in ER-positive and ER-negative mammary cancer in mice. Epidemiology. American Association for Cancer Research; 2011; 10.1158/1538-7445.am2011-1812
• Impact of body mass index on clinical outcomes in triple-negative breast cancer Cite
  Ademuyiwa FO, Groman A, O'Connor T, Ambrosone C, Watroba N, Edge SB. Impact of body mass index on clinical outcomes in triple-negative breast cancer. Cancer. Wiley; 2011; 117:4132-4140 10.1002/cncr.26019
• Risk of a Second Breast Cancer Associated with Hormone-Receptor and HER2/neu Status of the First Breast Cancer Cite
  Bessonova L, Taylor TH, Mehta RS, Zell JA, Anton-Culver H. Risk of a Second Breast Cancer Associated with Hormone-Receptor and HER2/neu Status of the First Breast Cancer. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2011; 20:389-396 10.1158/1055-9965.epi-10-1016
• Reproductive History and Oral Contraceptive Use in Relation to Risk of Triple-Negative Breast Cancer Cite
  Phipps AI, Chlebowski RT, Prentice R, McTiernan A, Wactawski-Wende J, Kuller LH, et al. Reproductive History and Oral Contraceptive Use in Relation to Risk of Triple-Negative Breast Cancer. JNCI Journal of the National Cancer Institute. Oxford University Press (OUP); 2011; 103:470-477 10.1093/jnci/djr030
• Stability of estrogen receptor status in breast carcinoma Cite
  Gong Y, Han EY, Guo M, Pusztai L, Sneige N. Stability of estrogen receptor status in breast carcinoma. Cancer. Wiley; 2010; 117:705-713 10.1002/cncr.25506
• Clinical outcome of triple negative breast cancer in BRCA1 mutation carriers and noncarriers Cite
  Lee LJ, Alexander B, Schnitt SJ, Comander A, Gallagher B, Garber JE, et al. Clinical outcome of triple negative breast cancer in BRCA1 mutation carriers and noncarriers. Cancer. Wiley; 2011; 117:3093-3100 10.1002/cncr.25911
• Higher population-based incidence rates of triple-negative breast cancer among young African-American women Cite
  Amirikia KC, Mills P, Bush J, Newman LA. Higher population-based incidence rates of triple-negative breast cancer among young African-American women. Cancer. Wiley; 2011; 117:2747-2753 10.1002/cncr.25862
• Breast Cancer Risk and Ovariectomy, Hysterectomy, and Tubal Sterilization in the Women's Contraceptive and Reproductive Experiences Study Cite
  Press DJ, Sullivan-Halley J, Ursin G, Deapen D, McDonald JA, Strom BL, et al. Breast Cancer Risk and Ovariectomy, Hysterectomy, and Tubal Sterilization in the Women's Contraceptive and Reproductive Experiences Study. American Journal of Epidemiology. Oxford University Press (OUP); 2010; 173:38-47 10.1093/aje/kwq339
• Body Fat Distribution and Risk of Premenopausal Breast Cancer in the Nurses' Health Study II Cite
  Harris HR, Willett WC, Terry KL, Michels KB. Body Fat Distribution and Risk of Premenopausal Breast Cancer in the Nurses' Health Study II. JNCI Journal of the National Cancer Institute. Oxford University Press (OUP); 2010; 103:273-278 10.1093/jnci/djq500
• Dietary patterns and risk of breast cancer Cite
  Baglietto L, Krishnan K, Severi G, Hodge A, Brinkman M, English DR, et al. Dietary patterns and risk of breast cancer. British Journal of Cancer. Springer Science and Business Media LLC; 2010; 104:524-531 10.1038/sj.bjc.6606044
• Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancer Cite
  Sparano JA, Wang M, Zhao F, Stearns V, Martino S, Ligibel JA, et al. Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancer. Cancer. Wiley; 2012; 118:5937-5946 10.1002/cncr.27527
• The anti-diabetic drug metformin suppresses the metastasis-associated protein CD24 in MDA-MB-468 triple-negative breast cancer cells Cite
  Menendez . The anti-diabetic drug metformin suppresses the metastasis-associated protein CD24 in MDA-MB-468 triple-negative breast cancer cells. Oncology Reports. Spandidos Publications; 2010; 25 10.3892/or_00001052
• Prognostic significance of triple negative breast cancer at tumor size 1 cm and smaller Cite
  Lai H, Kuo S, Chen L, Chi C, Chen S, Chang T, et al. Prognostic significance of triple negative breast cancer at tumor size 1 cm and smaller. European Journal of Surgical Oncology (EJSO). Elsevier BV; 2011; 37:18-24 10.1016/j.ejso.2010.10.003
• Anticancer Activities of an Anthocyanin-Rich Extract From Black Rice Against Breast Cancer Cells In Vitro and In Vivo Cite
  Hui C, Bin Y, Xiaoping Y, Long Y, Chunye C, Mantian M, et al. Anticancer Activities of an Anthocyanin-Rich Extract From Black Rice Against Breast Cancer Cells In Vitro and In Vivo. Nutrition and Cancer. Informa UK Limited; 2010; 62:1128-1136 10.1080/01635581.2010.494821
• Impact of treatment characteristics on response of different breast cancer phenotypes: pooled analysis of the German neo-adjuvant chemotherapy trials Cite
  von Minckwitz G, Untch M, Nüesch E, Loibl S, Kaufmann M, Kümmel S, et al. Impact of treatment characteristics on response of different breast cancer phenotypes: pooled analysis of the German neo-adjuvant chemotherapy trials. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2010; 125:145-156 10.1007/s10549-010-1228-x
• Prognosis and Outcome of Small (≤1 cm), Node‐Negative Breast Cancer on the Basis of Hormonal and HER‐2 Status Cite
  Amar S, McCullough AE, Tan W, Geiger XJ, Boughey JC, McNeil RB, et al. Prognosis and Outcome of Small (≤1 cm), Node‐Negative Breast Cancer on the Basis of Hormonal and HER‐2 Status. The Oncologist. Wiley; 2010; 15:1043-1049 10.1634/theoncologist.2010-0036
• Physical Activity and Risk of Breast Cancer Among Postmenopausal Women Cite
  Eliassen AH, Hankinson SE, Rosner B, Holmes MD, Willett WC. Physical Activity and Risk of Breast Cancer Among Postmenopausal Women. Archives of Internal Medicine. American Medical Association (AMA); 2010; 170 10.1001/archinternmed.2010.363
• Fruit and Vegetable Intake in Relation to Risk of Breast Cancer in the Black Women's Health Study Cite
  Boggs DA, Palmer JR, Wise LA, Spiegelman D, Stampfer MJ, Adams-Campbell LL, et al. Fruit and Vegetable Intake in Relation to Risk of Breast Cancer in the Black Women's Health Study. American Journal of Epidemiology. Oxford University Press (OUP); 2010; 172:1268-1279 10.1093/aje/kwq293
• Risk of breast cancer according to clinicopathologic features among long-term survivors of Hodgkin's lymphoma treated with radiotherapy Cite
  Dores GM, Anderson WF, Beane Freeman LE, Fraumeni JF, Curtis RE. Risk of breast cancer according to clinicopathologic features among long-term survivors of Hodgkin's lymphoma treated with radiotherapy. British Journal of Cancer. Springer Science and Business Media LLC; 2010; 103:1081-1084 10.1038/sj.bjc.6605877
• The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer Cite
  Gabos Z, Thoms J, Ghosh S, Hanson J, Deschênes J, Sabri S, et al. The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2010; 124:187-194 10.1007/s10549-010-1135-1
• Locoregional Recurrence in Patients With Triple-Negative Breast Cancer Cite
  Dragun AE, Pan J, Rai SN, Kruse B, Jain D. Locoregional Recurrence in Patients With Triple-Negative Breast Cancer. American Journal of Clinical Oncology. Ovid Technologies (Wolters Kluwer Health); 2011; 34:231-237 10.1097/coc.0b013e3181dea993
• Dietary energy availability affects primary and metastatic breast cancer and metformin efficacy Cite
  Phoenix KN, Vumbaca F, Fox MM, Evans R, Claffey KP. Dietary energy availability affects primary and metastatic breast cancer and metformin efficacy. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2009; 123:333-344 10.1007/s10549-009-0647-z
• Diagnosis of second breast cancer events after initial diagnosis of early stage breast cancer Cite
  Buist DSM, Abraham LA, Barlow WE, Krishnaraj A, Holdridge RC, Sickles EA, et al. Diagnosis of second breast cancer events after initial diagnosis of early stage breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2010; 124:863-873 10.1007/s10549-010-1106-6
• Oral Contraceptive Use and Estrogen/Progesterone Receptor–Negative Breast Cancer among African American Women Cite
  Rosenberg L, Boggs DA, Wise LA, Adams-Campbell LL, Palmer JR. Oral Contraceptive Use and Estrogen/Progesterone Receptor–Negative Breast Cancer among African American Women. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2010; 19:2073-2079 10.1158/1055-9965.epi-10-0428
• Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study Cite
  Bardia A, Olson JE, Vachon CM, Lazovich D, Vierkant RA, Wang AH, et al. Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2010; 126:149-155 10.1007/s10549-010-1074-x
• African ancestry and higher prevalence of triple-negative breast cancer Cite
  Stark A, Kleer CG, Martin I, Awuah B, Nsiah-Asare A, Takyi V, et al. African ancestry and higher prevalence of triple-negative breast cancer. Cancer. Wiley; 2010; 116:4926-4932 10.1002/cncr.25276
• Smoking and alcohol consumption in relation to risk of triple-negative breast cancer in a cohort of postmenopausal women Cite
  Kabat GC, Kim M, Phipps AI, Li CI, Messina CR, Wactawski-Wende J, et al. Smoking and alcohol consumption in relation to risk of triple-negative breast cancer in a cohort of postmenopausal women. Cancer Causes & Control. Springer Science and Business Media LLC; 2011; 22:775-783 10.1007/s10552-011-9750-7
• Determination of clear margin in breast-conserving surgery: Is 1 mm needed? Cite
  Geffrelot J, Toudic Emily F, Levy C, Blanc Fournier C, Segura C, Switsers O, et al. Determination of clear margin in breast-conserving surgery: Is 1 mm needed?. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010; 28:515-515 10.1200/jco.2010.28.15_suppl.515
• Discordance in hormone receptor status in breast cancer during tumor progression. Cite
  Karlsson E, Lindström LS, Wilking U, Skoog L, Johansson U, Bergh J. Discordance in hormone receptor status in breast cancer during tumor progression.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010; 28:1009-1009 10.1200/jco.2010.28.15_suppl.1009
• Prognosis of medullary breast cancer: Analyses of 13 International Breast Cancer Study Group (IBCSG) trials. Cite
  Huober JB, Gelber S, Thürlimann B, Regan MM, Price KN, Goldhirsch A, et al. Prognosis of medullary breast cancer: Analyses of 13 International Breast Cancer Study Group (IBCSG) trials.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010; 28:630-630 10.1200/jco.2010.28.15_suppl.630
• The prognostic impact of age in patients with triple-negative breast cancer Cite
  Liedtke C, Hess KR, Karn T, Rody A, Kiesel L, Hortobagyi GN, et al. The prognostic impact of age in patients with triple-negative breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2013; 138:591-599 10.1007/s10549-013-2461-x
• Effects of Exercise Training on Antitumor Efficacy of Doxorubicin in MDA-MB-231 Breast Cancer Xenografts Cite
  Jones LW, Eves ND, Courneya KS, Chiu BK, Baracos VE, Hanson J, et al. Effects of Exercise Training on Antitumor Efficacy of Doxorubicin in MDA-MB-231 Breast Cancer Xenografts. Clinical Cancer Research. American Association for Cancer Research (AACR); 2005; 11:6695-6698 10.1158/1078-0432.ccr-05-0844
• Selenium nanoparticles inhibit the growth of HeLa and MDA-MB-231 cells through induction of S phase arrest Cite
  Luo H, Wang F, Bai Y, Chen T, Zheng W. Selenium nanoparticles inhibit the growth of HeLa and MDA-MB-231 cells through induction of S phase arrest. Colloids and Surfaces B: Biointerfaces. Elsevier BV; 2012; 94:304-308 10.1016/j.colsurfb.2012.02.006
• Intrinsic Breast Tumor Subtypes, Race, and Long-Term Survival in the Carolina Breast Cancer Study Cite
  O'Brien KM, Cole SR, Tse C, Perou CM, Carey LA, Foulkes WD, et al. Intrinsic Breast Tumor Subtypes, Race, and Long-Term Survival in the Carolina Breast Cancer Study. Clinical Cancer Research. American Association for Cancer Research (AACR); 2010; 16:6100-6110 10.1158/1078-0432.ccr-10-1533
• Abstract 5713: Omega-3 fatty acid molecular and cellular modulation of in vitro models of high-risk breast cancer Cite
  Chen CH, Cavazos DA, Apte SA, Fabian C, Hursting S, deGraffenried LA. Abstract 5713: Omega-3 fatty acid molecular and cellular modulation of in vitro models of high-risk breast cancer. Prevention Research. American Association for Cancer Research; 2010; 10.1158/1538-7445.am10-5713
• Abstract 5583: Innate immune profile of inflammatory breast cancer patients Cite
  Cohen EN, Gao H, Lee B, Andreopoulou E, Jackson SA, Parker CA, et al. Abstract 5583: Innate immune profile of inflammatory breast cancer patients. Clinical Research. American Association for Cancer Research; 2010; 10.1158/1538-7445.am10-5583
• Blueberry Phytochemicals Inhibit Growth and Metastatic Potential of MDA-MB-231 Breast Cancer Cells through Modulation of the Phosphatidylinositol 3-Kinase Pathway Cite
  Adams LS, Phung S, Yee N, Seeram NP, Li L, Chen S. Blueberry Phytochemicals Inhibit Growth and Metastatic Potential of MDA-MB-231 Breast Cancer Cells through Modulation of the Phosphatidylinositol 3-Kinase Pathway. Cancer Research. American Association for Cancer Research (AACR); 2010; 70:3594-3605 10.1158/0008-5472.can-09-3565
• Worse prognosis of metaplastic breast cancer patients than other patients with triple-negative breast cancer Cite
  Jung S, Kim HY, Nam B, Min SY, Lee SJ, Park C, et al. Worse prognosis of metaplastic breast cancer patients than other patients with triple-negative breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2010; 120:627-637 10.1007/s10549-010-0780-8
• Risk Factors for Triple-Negative Breast Cancer in Women Under the Age of 45 Years Cite
  Dolle JM, Daling JR, White E, Brinton LA, Doody DR, Porter PL, et al. Risk Factors for Triple-Negative Breast Cancer in Women Under the Age of 45 Years. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2009; 18:1157-1166 10.1158/1055-9965.epi-08-1005
• Black Race Is Associated with a Worse Outcome in Patients with Hormone Receptor Positive, HER2-Normal Breast Cancer Treated with Adjuvant Chemohormonal Therapy. Cite
  Sparano J, Wang W, Stearns V, Martino S, Jones V, Perez E, et al. Black Race Is Associated with a Worse Outcome in Patients with Hormone Receptor Positive, HER2-Normal Breast Cancer Treated with Adjuvant Chemohormonal Therapy.. General Session Abstracts. American Association for Cancer Research; 2009; 10.1158/0008-5472.sabcs-09-37
• Second Primary Breast Cancer Occurrence According to Hormone Receptor Status Cite
  Kurian AW, McClure LA, John EM, Horn-Ross PL, Ford JM, Clarke CA. Second Primary Breast Cancer Occurrence According to Hormone Receptor Status. JNCI Journal of the National Cancer Institute. Oxford University Press (OUP); 2009; 101:1058-1065 10.1093/jnci/djp181
• The association of metabolic syndrome with triple-negative breast cancer Cite
  Maiti B, Kundranda MN, Spiro TP, Daw HA. The association of metabolic syndrome with triple-negative breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2009; 121:479-483 10.1007/s10549-009-0591-y
• Vitamin D From Dietary Intake and Sunlight Exposure and the Risk of Hormone-Receptor-Defined Breast Cancer Cite
  Blackmore KM, Lesosky M, Barnett H, Raboud JM, Vieth R, Knight JA. Vitamin D From Dietary Intake and Sunlight Exposure and the Risk of Hormone-Receptor-Defined Breast Cancer. American Journal of Epidemiology. Oxford University Press (OUP); 2008; 168:915-924 10.1093/aje/kwn198
• Effects of the olive, extra virgin olive and canola oils on cisplatin-induced clastogenesis in Wistar rats Cite
  Evangelista CMW, Antunes LMG, Francescato HD, Bianchi MLP. Effects of the olive, extra virgin olive and canola oils on cisplatin-induced clastogenesis in Wistar rats. Food and Chemical Toxicology. Elsevier BV; 2004; 42:1291-1297 10.1016/j.fct.2004.03.006
• Fatty acid uptake by breast cancer cells (MDA-MB-231): Effects of insulin, leptin, adiponectin, and TNFα Cite
  Kaur B, Jørgensen A, Duttaroy AK. Fatty acid uptake by breast cancer cells (MDA-MB-231): Effects of insulin, leptin, adiponectin, and TNFα. Prostaglandins, Leukotrienes and Essential Fatty Acids. Elsevier BV; 2009; 80:93-99 10.1016/j.plefa.2009.01.002
• Sulforaphane induces cell type–specific apoptosis in human breast cancer cell lines Cite
  Pledgie-Tracy A, Sobolewski MD, Davidson NE. Sulforaphane induces cell type–specific apoptosis in human breast cancer cell lines. Molecular Cancer Therapeutics. American Association for Cancer Research (AACR); 2007; 6:1013-1021 10.1158/1535-7163.mct-06-0494
• Coffee Consumption and CYP1A2*1F Genotype Modify Age at Breast Cancer Diagnosis and Estrogen Receptor Status Cite
  Bågeman E, Ingvar C, Rose C, Jernström H. Coffee Consumption and CYP1A2*1F Genotype Modify Age at Breast Cancer Diagnosis and Estrogen Receptor Status. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2008; 17:895-901 10.1158/1055-9965.epi-07-0555
• Apple Phytochemical Extracts Inhibit Proliferation of Estrogen-Dependent and Estrogen-Independent Human Breast Cancer Cells through Cell Cycle Modulation Cite
  Sun J, Liu RH. Apple Phytochemical Extracts Inhibit Proliferation of Estrogen-Dependent and Estrogen-Independent Human Breast Cancer Cells through Cell Cycle Modulation. Journal of Agricultural and Food Chemistry. American Chemical Society (ACS); 2008; 56:11661-11667 10.1021/jf8021223